A condition in which the intraocular pressure is elevated above normal and which may lead to glaucoma.
The pressure of the fluids in the eye.
Glaucoma in which the angle of the anterior chamber is open and the trabecular meshwork does not encroach on the base of the iris.
An ocular disease, occurring in many forms, having as its primary characteristics an unstable or a sustained increase in the intraocular pressure which the eye cannot withstand without damage to its structure or impairment of its function. The consequences of the increased pressure may be manifested in a variety of symptoms, depending upon type and severity, such as excavation of the optic disk, hardness of the eyeball, corneal anesthesia, reduced visual acuity, seeing of colored halos around lights, disturbed dark adaptation, visual field defects, and headaches. (Dictionary of Visual Science, 4th ed)
Analogs or derivatives of prostaglandins F that do not occur naturally in the body. They do not include the product of the chemical synthesis of hormonal PGF.
Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more.
Measurement of ocular tension (INTRAOCULAR PRESSURE) with a tonometer. (Cline, et al., Dictionary of Visual Science, 4th ed)
A beta-adrenergic antagonist similar in action to PROPRANOLOL. The levo-isomer is the more active. Timolol has been proposed as an antihypertensive, antiarrhythmic, antiangina, and antiglaucoma agent. It is also used in the treatment of MIGRAINE DISORDERS and tremor.
Increased VASCULAR RESISTANCE in the PULMONARY CIRCULATION, usually secondary to HEART DISEASES or LUNG DISEASES.
Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS.
The portion of the optic nerve seen in the fundus with the ophthalmoscope. It is formed by the meeting of all the retinal ganglion cell axons as they enter the optic nerve.
A synthetic prostaglandin F2alpha analog. The compound has luteolytic effects and is used for the synchronization of estrus in cattle.
Conditions which produce injury or dysfunction of the second cranial or optic nerve, which is generally considered a component of the central nervous system. Damage to optic nerve fibers may occur at or near their origin in the retina, at the optic disk, or in the nerve, optic chiasm, optic tract, or lateral geniculate nuclei. Clinical manifestations may include decreased visual acuity and contrast sensitivity, impaired color vision, and an afferent pupillary defect.
The total area or space visible in a person's peripheral vision with the eye looking straightforward.
Sterile solutions that are intended for instillation into the eye. It does not include solutions for cleaning eyeglasses or CONTACT LENS SOLUTIONS.
Method of measuring and mapping the scope of vision, from central to peripheral of each eye.
Substances added to pharmaceutical preparations to protect them from chemical change or microbial action. They include ANTI-BACTERIAL AGENTS and antioxidants.
A porelike structure surrounding the entire circumference of the anterior chamber through which aqueous humor circulates to the canal of Schlemm.
Neurons of the innermost layer of the retina, the internal plexiform layer. They are of variable sizes and shapes, and their axons project via the OPTIC NERVE to the brain. A small subset of these cells act as photoreceptors with projections to the SUPRACHIASMATIC NUCLEUS, the center for regulating CIRCADIAN RHYTHM.
Compounds obtained by chemical synthesis that are analogs or derivatives of naturally occurring prostaglandins and that have similar activity.
The clear, watery fluid which fills the anterior and posterior chambers of the eye. It has a refractive index lower than the crystalline lens, which it surrounds, and is involved in the metabolism of the cornea and the crystalline lens. (Cline et al., Dictionary of Visual Science, 4th ed, p319)
Persistent high BLOOD PRESSURE due to KIDNEY DISEASES, such as those involving the renal parenchyma, the renal vasculature, or tumors that secrete RENIN.
Visual impairments limiting one or more of the basic functions of the eye: visual acuity, dark adaptation, color vision, or peripheral vision. These may result from EYE DISEASES; OPTIC NERVE DISEASES; VISUAL PATHWAY diseases; OCCIPITAL LOBE diseases; OCULAR MOTILITY DISORDERS; and other conditions (From Newell, Ophthalmology: Principles and Concepts, 7th ed, p132).
PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS.
The application of drug preparations to the surfaces of the body, especially the skin (ADMINISTRATION, CUTANEOUS) or mucous membranes. This method of treatment is used to avoid systemic side effects when high doses are required at a localized area or as an alternative systemic administration route, to avoid hepatic processing for example.
Abnormal increase of resistance to blood flow within the hepatic PORTAL SYSTEM, frequently seen in LIVER CIRRHOSIS and conditions with obstruction of the PORTAL VEIN.
Agents causing contraction of the pupil of the eye. Some sources use the term miotics only for the parasympathomimetics but any drug used to induce miosis is included here.
The L-Isomer of bunolol.
The organ of sight constituting a pair of globular organs made up of a three-layered roughly spherical structure specialized for receiving and responding to light.
Recording of electric potentials in the retina after stimulation by light.
The space in the eye, filled with aqueous humor, bounded anteriorly by the cornea and a small portion of the sclera and posteriorly by a small portion of the ciliary body, the iris, and that part of the crystalline lens which presents through the pupil. (Cline et al., Dictionary of Visual Science, 4th ed, p109)
Application of pharmaceutically active agents on the tissues of the EYE.
Hypertension due to RENAL ARTERY OBSTRUCTION or compression.
The 2nd cranial nerve which conveys visual information from the RETINA to the brain. The nerve carries the axons of the RETINAL GANGLION CELLS which sort at the OPTIC CHIASM and continue via the OPTIC TRACTS to the brain. The largest projection is to the lateral geniculate nuclei; other targets include the SUPERIOR COLLICULI and the SUPRACHIASMATIC NUCLEI. Though known as the second cranial nerve, it is considered part of the CENTRAL NERVOUS SYSTEM.
Examination of the angle of the anterior chamber of the eye with a specialized optical instrument (gonioscope) or a contact prism lens.
Imaging methods that result in sharp images of objects located on a chosen plane and blurred images located above or below the plane.
Examination of the interior of the eye with an ophthalmoscope.
Conjunctival diseases refer to a broad range of disorders that affect the conjunctiva, the mucous membrane covering the inner surface of the eyelids and the outer layer of the eyeball, causing symptoms such as redness, itching, irritation, discharge, and/or inflammation.
Method of making images on a sensitized surface by exposure to light or other radiant energy.
A mixture of alkylbenzyldimethylammonium compounds. It is a bactericidal quaternary ammonium detergent used topically in medicaments, deodorants, mouthwashes, as a surgical antiseptic, and as a as preservative and emulsifier in drugs and cosmetics.
A condition of markedly elevated BLOOD PRESSURE with DIASTOLIC PRESSURE usually greater than 120 mm Hg. Malignant hypertension is characterized by widespread vascular damage, PAPILLEDEMA, retinopathy, HYPERTENSIVE ENCEPHALOPATHY, and renal dysfunction.
Naturally occurring or experimentally induced animal diseases with pathological processes sufficiently similar to those of human diseases. They are used as study models for human diseases.
Clarity or sharpness of OCULAR VISION or the ability of the eye to see fine details. Visual acuity depends on the functions of RETINA, neuronal transmission, and the interpretative ability of the brain. Normal visual acuity is expressed as 20/20 indicating that one can see at 20 feet what should normally be seen at that distance. Visual acuity can also be influenced by brightness, color, and contrast.
Surgical techniques on the CORNEA employing LASERS, especially for reshaping the CORNEA to correct REFRACTIVE ERRORS.
The administration of therapeutic agents drop by drop, as eye drops, ear drops, or nose drops. It is also administered into a body space or cavity through a catheter. It differs from THERAPEUTIC IRRIGATION in that the irrigate is removed within minutes, but the instillate is left in place.
The ten-layered nervous tissue membrane of the eye. It is continuous with the OPTIC NERVE and receives images of external objects and transmits visual impulses to the brain. Its outer surface is in contact with the CHOROID and the inner surface with the VITREOUS BODY. The outer-most layer is pigmented, whereas the inner nine layers are transparent.
A glucocorticoid employed, usually as eye drops, in the treatment of allergic and inflammatory conditions of the eye. It has also been used topically in the treatment of various skin disorders. (From Martindale, The Extra Pharmacopoeia, 30th ed, p732)
The front third of the eyeball that includes the structures between the front surface of the cornea and the front of the VITREOUS BODY.
Measurement of light given off by fluorescein in order to assess the integrity of various ocular barriers. The method is used to investigate the blood-aqueous barrier, blood-retinal barrier, aqueous flow measurements, corneal endothelial permeability, and tear flow dynamics.
The transparent anterior portion of the fibrous coat of the eye consisting of five layers: stratified squamous CORNEAL EPITHELIUM; BOWMAN MEMBRANE; CORNEAL STROMA; DESCEMET MEMBRANE; and mesenchymal CORNEAL ENDOTHELIUM. It serves as the first refracting medium of the eye. It is structurally continuous with the SCLERA, avascular, receiving its nourishment by permeation through spaces between the lamellae, and is innervated by the ophthalmic division of the TRIGEMINAL NERVE via the ciliary nerves and those of the surrounding conjunctiva which together form plexuses. (Cline et al., Dictionary of Visual Science, 4th ed)
Methods and procedures for the diagnosis of diseases of the eye or of vision disorders.
Retinal diseases refer to a diverse group of vision-threatening disorders that affect the retina's structure and function, including age-related macular degeneration, diabetic retinopathy, retinal detachment, retinitis pigmentosa, and macular edema, among others.
The use of green light-producing LASERS to stop bleeding. The green light is selectively absorbed by HEMOGLOBIN, thus triggering BLOOD COAGULATION.
Thiophenes are aromatic heterocyclic organic compounds containing a five-membered ring with four carbon atoms and one sulfur atom, which are found in various natural substances and synthesized for use in pharmaceuticals and agrochemicals.
An aspect of personal behavior or lifestyle, environmental exposure, or inborn or inherited characteristic, which, on the basis of epidemiologic evidence, is known to be associated with a health-related condition considered important to prevent.
The most anterior portion of the uveal layer, separating the anterior chamber from the posterior. It consists of two layers - the stroma and the pigmented epithelium. Color of the iris depends on the amount of melanin in the stroma on reflection from the pigmented epithelium.
The transparent, semigelatinous substance that fills the cavity behind the CRYSTALLINE LENS of the EYE and in front of the RETINA. It is contained in a thin hyaloid membrane and forms about four fifths of the optic globe.
Diseases, dysfunctions, or disorders of or located in the iris.
Any surgical procedure for treatment of glaucoma by means of puncture or reshaping of the trabecular meshwork. It includes goniotomy, trabeculectomy, and laser perforation.
The white, opaque, fibrous, outer tunic of the eyeball, covering it entirely excepting the segment covered anteriorly by the cornea. It is essentially avascular but contains apertures for vessels, lymphatics, and nerves. It receives the tendons of insertion of the extraocular muscles and at the corneoscleral junction contains the canal of Schlemm. (From Cline et al., Dictionary of Visual Science, 4th ed)
Drugs that bind to but do not activate beta-adrenergic receptors thereby blocking the actions of beta-adrenergic agonists. Adrenergic beta-antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches, and anxiety.
The selectively permeable barrier, in the EYE, formed by the nonpigmented layer of the EPITHELIUM of the CILIARY BODY, and the ENDOTHELIUM of the BLOOD VESSELS of the IRIS. TIGHT JUNCTIONS joining adjacent cells keep the barrier between cells continuous.
'Eye proteins' are structural or functional proteins, such as crystallins, opsins, and collagens, located in various parts of the eye, including the cornea, lens, retina, and aqueous humor, that contribute to maintaining transparency, refractive power, phototransduction, and overall integrity of the visual system.
Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group.
Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease.
Infection caused by the protozoan parasite TOXOPLASMA in which there is extensive connective tissue proliferation, the retina surrounding the lesions remains normal, and the ocular media remain clear. Chorioretinitis may be associated with all forms of toxoplasmosis, but is usually a late sequel of congenital toxoplasmosis. The severe ocular lesions in infants may lead to blindness.
A slowly hydrolyzed muscarinic agonist with no nicotinic effects. Pilocarpine is used as a miotic and in the treatment of glaucoma.
A barbiturate that is administered intravenously for the production of complete anesthesia of short duration, for the induction of general anesthesia, or for inducing a hypnotic state. (From Martindale, The Extra Pharmacopoeia, 30th ed, p919)
A condition in pregnant women with elevated systolic (>140 mm Hg) and diastolic (>90 mm Hg) blood pressure on at least two occasions 6 h apart. HYPERTENSION complicates 8-10% of all pregnancies, generally after 20 weeks of gestation. Gestational hypertension can be divided into several broad categories according to the complexity and associated symptoms, such as EDEMA; PROTEINURIA; SEIZURES; abnormalities in BLOOD COAGULATION and liver functions.
The point or frequency at which all flicker of an intermittent light stimulus disappears.
Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care. (Dictionary of Health Services Management, 2d ed)
The electric response evoked in the cerebral cortex by visual stimulation or stimulation of the visual pathways.
A group of CORTICOSTEROIDS that affect carbohydrate metabolism (GLUCONEOGENESIS, liver glycogen deposition, elevation of BLOOD SUGAR), inhibit ADRENOCORTICOTROPIC HORMONE secretion, and possess pronounced anti-inflammatory activity. They also play a role in fat and protein metabolism, maintenance of arterial blood pressure, alteration of the connective tissue response to injury, reduction in the number of circulating lymphocytes, and functioning of the central nervous system.
A class of compounds that reduces the secretion of H+ ions by the proximal kidney tubule through inhibition of CARBONIC ANHYDRASES.
The thin, highly vascular membrane covering most of the posterior of the eye between the RETINA and SCLERA.
Elements of limited time intervals, contributing to particular results or situations.
Quinoxalines are heterocyclic organic compounds consisting of a benzene fused to a pyrazine ring, which have been studied for their potential antibacterial, antifungal, and anticancer properties.
An optical source that emits photons in a coherent beam. Light Amplification by Stimulated Emission of Radiation (LASER) is brought about using devices that transform light of varying frequencies into a single intense, nearly nondivergent beam of monochromatic radiation. Lasers operate in the infrared, visible, ultraviolet, or X-ray regions of the spectrum.
The aperture in the iris through which light passes.
A species of the genus MACACA which typically lives near the coast in tidal creeks and mangrove swamps primarily on the islands of the Malay peninsula.
Organic compounds containing the -CO-NH2 radical. Amides are derived from acids by replacement of -OH by -NH2 or from ammonia by the replacement of H by an acyl group. (From Grant & Hackh's Chemical Dictionary, 5th ed)
A method of non-invasive, continuous measurement of MICROCIRCULATION. The technique is based on the values of the DOPPLER EFFECT of low-power laser light scattered randomly by static structures and moving tissue particulates.
Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons.
An esterified form of TRIAMCINOLONE. It is an anti-inflammatory glucocorticoid used topically in the treatment of various skin disorders. Intralesional, intramuscular, and intra-articular injections are also administered under certain conditions.
The minimum amount of stimulus energy necessary to elicit a sensory response.
A surgical specialty concerned with the structure and function of the eye and the medical and surgical treatment of its defects and diseases.
A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment.
A group of compounds that contain the structure SO2NH2.
Slender processes of NEURONS, including the AXONS and their glial envelopes (MYELIN SHEATH). Nerve fibers conduct nerve impulses to and from the CENTRAL NERVOUS SYSTEM.
The short wide vessel arising from the conus arteriosus of the right ventricle and conveying unaerated blood to the lungs.
Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series.
An anti-inflammatory 9-fluoro-glucocorticoid.
The worsening of a disease over time. This concept is most often used for chronic and incurable diseases where the stage of the disease is an important determinant of therapy and prognosis.
A strain of Rattus norvegicus with elevated blood pressure used as a model for studying hypertension and stroke.
Diseases affecting the eye.
Albinism affecting the eye in which pigment of the hair and skin is normal or only slightly diluted. The classic type is X-linked (Nettleship-Falls), but an autosomal recessive form also exists. Ocular abnormalities may include reduced pigmentation of the iris, nystagmus, photophobia, strabismus, and decreased visual acuity.
The functional superiority and preferential use of one eye over the other. The term is usually applied to superiority in sighting (VISUAL PERCEPTION) or motor task but not difference in VISUAL ACUITY or dysfunction of one of the eyes. Ocular dominance can be modified by visual input and NEUROTROPHIC FACTORS.
A highly specific (Leu-Leu) endopeptidase that generates ANGIOTENSIN I from its precursor ANGIOTENSINOGEN, leading to a cascade of reactions which elevate BLOOD PRESSURE and increase sodium retention by the kidney in the RENIN-ANGIOTENSIN SYSTEM. The enzyme was formerly listed as EC 3.4.99.19.
Partial or complete opacity on or in the lens or capsule of one or both eyes, impairing vision or causing blindness. The many kinds of cataract are classified by their morphology (size, shape, location) or etiology (cause and time of occurrence). (Dorland, 27th ed)
The number of CELLS of a specific kind, usually measured per unit volume or area of sample.
Increased pressure within the cranial vault. This may result from several conditions, including HYDROCEPHALUS; BRAIN EDEMA; intracranial masses; severe systemic HYPERTENSION; PSEUDOTUMOR CEREBRI; and other disorders.
Techniques for measuring blood pressure.
Refraction of LIGHT effected by the media of the EYE.
Tumors or cancer of the EYE.
Body organ that filters blood for the secretion of URINE and that regulates ion concentrations.
A strain of Rattus norvegicus used as a normotensive control for the spontaneous hypertensive rats (SHR).
Mental process to visually perceive a critical number of facts (the pattern), such as characters, shapes, displays, or designs.
A strain of albino rat used widely for experimental purposes because of its calmness and ease of handling. It was developed by the Sprague-Dawley Animal Company.
Nerve fibers that are capable of rapidly conducting impulses away from the neuron cell body.
Studies in which subsets of a defined population are identified. These groups may or may not be exposed to factors hypothesized to influence the probability of the occurrence of a particular disease or other outcome. Cohorts are defined populations which, as a whole, are followed in an attempt to determine distinguishing subgroup characteristics.
The total number of cases of a given disease in a specified population at a designated time. It is differentiated from INCIDENCE, which refers to the number of new cases in the population at a given time.
The species Oryctolagus cuniculus, in the family Leporidae, order LAGOMORPHA. Rabbits are born in burrows, furless, and with eyes and ears closed. In contrast with HARES, rabbits have 22 chromosome pairs.
Insertion of an artificial lens to replace the natural CRYSTALLINE LENS after CATARACT EXTRACTION or to supplement the natural lens which is left in place.
An imaging method using LASERS that is used for mapping subsurface structure. When a reflective site in the sample is at the same optical path length (coherence) as the reference mirror, the detector observes interference fringes.
A steroid metabolite that is the 11-deoxy derivative of CORTICOSTERONE and the 21-hydroxy derivative of PROGESTERONE.
A statistical technique that isolates and assesses the contributions of categorical independent variables to variation in the mean of a continuous dependent variable.
The flow of BLOOD through or around an organ or region of the body.
Disorders that feature impairment of eye movements as a primary manifestation of disease. These conditions may be divided into infranuclear, nuclear, and supranuclear disorders. Diseases of the eye muscles or oculomotor cranial nerves (III, IV, and VI) are considered infranuclear. Nuclear disorders are caused by disease of the oculomotor, trochlear, or abducens nuclei in the BRAIN STEM. Supranuclear disorders are produced by dysfunction of higher order sensory and motor systems that control eye movements, including neural networks in the CEREBRAL CORTEX; BASAL GANGLIA; CEREBELLUM; and BRAIN STEM. Ocular torticollis refers to a head tilt that is caused by an ocular misalignment. Opsoclonus refers to rapid, conjugate oscillations of the eyes in multiple directions, which may occur as a parainfectious or paraneoplastic condition (e.g., OPSOCLONUS-MYOCLONUS SYNDROME). (Adams et al., Principles of Neurology, 6th ed, p240)
Photosensitive proteins expressed in the ROD PHOTORECEPTOR CELLS. They are the protein components of rod photoreceptor pigments such as RHODOPSIN.

Asymmetry in optic disc parameters: the Blue Mountains Eye Study. (1/803)

PURPOSE: To examine asymmetry in vertical optic disc parameters among subjects classified as normal, as having ocular hypertension (OH), and as having open-angle glaucoma (OAG) in a population-based sample. METHODS: The Blue Mountains Eye Study examined 3654 people aged 49 to 97 years, including 2929 normal subjects, 118 with OH, and 79 with OAG in the groups of interest for the asymmetry study. Optic disc parameters were measured in a masked manner from stereo optic disc photographs. RESULTS: Vertical disc diameter asymmetry (the absolute value of left minus right disc diameters) was similar among normal, OH, and OAG groups (median, 0.07-0.08 mm). Vertical cup- disc ratio asymmetry was higher in patients with OAG (median, 0.11) than in normal subjects (median, 0.06; P < 0.0001) and in those with OH (median, 0.05; P < 0.0001) but was similar between normal subjects and patients with OH (P = 0.17). A cup- disc ratio asymmetry of 0.2 or more was found in 24% of patients with OAG, compared with 1% of patients with OH and 6% of normal subjects. Corresponding rates for cup- disc ratio asymmetry of 0.3 or more in these three groups were 10%, 0%, and 1%, respectively. Using multiple linear regression, cup-disc ratio asymmetry was associated with disc diameter asymmetry and intraocular pressure asymmetry. However, these two factors explained only 3% of the variability of cup- disc ratio asymmetry and 20% of cup diameter asymmetry. CONCLUSIONS: Despite differences between the OAG group and either the OH or normal groups, asymmetry alone was not useful in identifying patients with OAG. At all levels of asymmetry, subjects were more likely to be classified as normal than with OH or OAG.  (+info)

Mechanism of exercise-induced ocular hypotension. (2/803)

PURPOSE: Although acute dynamic exercise reduces intraocular pressure (IOP), the factors that provoke this response remain ill-defined. To determine whether changes in colloid osmotic pressure (COP) cause the IOP changes during exercise, standardized exercise was performed after dehydration and hydration with isosmotic fluid. METHODS: Progressive cycle ergometer exercise to volitional exhaustion was performed after 4 hours' dehydration, and after hydration with 946 ml isosmotic liquid (345 mOsM). In each experiment, venous blood taken before and immediately after exercise was analyzed for hematocrit, plasma protein concentration, total plasma osmolality, and plasma COP. RESULTS: Exercise in both experiments significantly reduced IOP and elevated COP (each P < 0.01). Dehydration, compared with hydration, also significantly reduced IOP and elevated COP, when measured before and after exercise (P < 0.05). The correlation of mean IOP with mean COP, over the entire range created by varying exercise and hydration statuses, was statistically significant (r = -0.99; P < 0.001). In contrast, other indexes of hydration status, including hematocrit, total plasma osmolality, and plasma protein concentration, failed to change as IOP changed and failed to correlate with IOP, on either a group or individual basis, in conditions of varying levels of exercise and hydration. CONCLUSIONS: Acute dynamic exercise and isosmotic fluid ingestion each seem to change IOP through changes in COP.  (+info)

The use of topical aqueous suppressants in the prevention of postoperative intraocular pressure elevation following pars plana vitrectomy with long-acting gas tamponade. (3/803)

PURPOSE: To determine if topical aqueous suppressant therapy applied after pars plana vitrectomy (PPV) with gas tamponade successfully prevents postoperative elevation of intraocular pressure (IOP). METHODS: A prospective, controlled study was performed on patients who met inclusion criteria and underwent PPV with gas tamponade (SF6 18%-20% or C3F8 12%-16%) over a 1-year period. Treatment eyes received topical aqueous suppressants at the end of surgery. Postoperative IOP checks were performed at 4 to 6 hours, 1 day, and 1 week. RESULTS: Twenty-one control (C) and 20 treatment (T) eyes met the inclusion criteria. The IOP (in mm Hg) measured at 4 to 6 hours (23.05 [C], 14.73 [T] and 1 day (23.24 [C], 17.28 [T]) postoperatively showed a statistically significant difference between the groups (P = .0038) at 4 to 6 hours, and a trend toward significance (P = .057) at 1 day. Eleven control and 3 treatment eyes had an IOP spike above 25 mm Hg at 4 to 6 hours or 1 day postoperatively (P = .02), and 6 control and 1 treatment eye had a postoperative IOP above 30 mm Hg. A pressure rise above 40 mm Hg was seen in 2 control eyes and no treatment eyes. CONCLUSIONS: Use of topical aqueous suppressants following PPV with long-acting gas tamponade is effective in preventing significant postoperative IOP elevation in a majority of cases.  (+info)

Detection of optic disc change with the Heidelberg retina tomograph before confirmed visual field change in ocular hypertensives converting to early glaucoma. (4/803)

AIM: To determine whether analysis of sequential optic disc images obtained with the Heidelberg retina tomograph (HRT) is able to demonstrate optic disc change before the development of reproducible field defects in a group of ocular hypertensive (OHT) patients converting to early glaucoma. METHODS: Two groups were analysed: (1) 13 eyes of 13 OHT patients who subsequently developed reproducible field defects (converters); and (2) 13 eyes of 11 normal control subjects. Two sequential optic disc images were obtained using the HRT (median separation between images was 12 months for the converters and 13 months for the normals). The second image in the converter group was obtained before confirmed visual field loss. The optic disc variables were analysed both globally and segmentally using HRT software version 1.11. The Wilcoxon signed rank test was used to determine if there were any significant differences between the variables of the two image sets. RESULTS: Significant optic disc change was demonstrated in the group of converters: (1) global variables: the cup area increased by 9.7%, the C/D area ratio increased by 10.5%, and the rim area decreased by 6.9%; (2) segmental variables: the superonasal cup area increased by 11.0%, the superonasal C/D area ratio increased 11.7%, and the inferonasal cup volume increased by 28.4%. The temporal rim volume decreased by 15.6%, the inferotemporal rim volume decreased by 23.6%, and the rim area in the superonasal and superotemporal segments decreased by 6.6% and 6.9% respectively. CONCLUSION: Analysis of sequential optic disc images on the HRT allowed the detection of glaucomatous change before confirmed visual field change in a group of OHT patients converting to early glaucoma.  (+info)

Visual function correlates with nerve fiber layer thickness in eyes affected by ocular hypertension. (5/803)

PURPOSE: To test whether the high variability observed when measuring pattern electroretinogram (PERG), visual evoked potentials (VEP), and spatial contrast sensitivity (SCS) in eyes with ocular hypertension is associated with variation in nerve fiber layer thickness, as measured by optical coherence tomography (OCT). METHODS: The study involved 32 untreated eyes (32 patients; age range, 29-64 years) showing a normal whiteon-white 24/2 Humphrey (San Leandro, CA) perimetry, IOP between 23 and 28 mm Hg, best corrected acuity of 20/20 or better, and none of the following papillary signs on conventional color stereo slides: rim notch(es), peripapillary splinter hemorrhages, or increased vertical-to-horizontal cup-to-disc ratio. On recruitment, each eye underwent SCS testing, OCT, PERG, and VEP recordings. Linear regression (Pearson's test) or Spearman's rank regression was adopted for the analysis of the data. RESULTS: The 95% confidence limits of the electrophysiological data were: PERG P50 latency, 59.3 to 63 msec; PERG P50 to N95 amplitude, 0.74 to 1.15 cmV; VEP P100 latency, 113 to 118 msec; VEP N75 to P100 amplitude, 3.81 to 4.90 micromV. The 360 degrees nerve fiber layer thickness overall (NFLO) ranged between 113 and 169 microm (145+/-16 microm; mean+/-SD) and significantly correlated with PERG P50 to N95 amplitude (r: 0.518; P = 0.002), PERG P50 latency (r: -0.470; P = 0.007), VEP N75 to P100 amplitude (r: 0.460; P = 0.008), VEP P100 latency (r = -0.422; P = 0.016) and SCS at 3 cyc/deg (r: -0.358; P = 0.044). CONCLUSIONS: The variability of PERG, VEP, and SCS testing observed in eyes with ocular hypertension is associated with differences in NFL thickness (the thinner the layer, the worse the visual function).  (+info)

Correlation of pattern electroretinogram with optic disc cup shape in ocular hypertension. (6/803)

PURPOSE: To evaluate the correlation of pattern electroretinogram (PERG), an index of inner retinal function, with confocal scanning laser (CSLO) optic disc structural parameters in ocular hypertension (OHT). METHODS: Thirty-four patients with OHT, normal white-on-white (Humphrey 30-2) perimetry, and normal clinical optic discs were examined with PERG and CSLO disc analysis. Two groups of normal subjects (n = 38 and 18, for PERG and CSLO, respectively) and a group of 12 patients with early open-angle glaucoma (EOAG) were also tested. Pattern electroretinogram amplitudes were measured in response to sinusoidal gratings of variable spatial frequency (0.58-5.8 cycles/degree), modulated in counter-phase at 7.5 Hz. Morphometric optic disc parameters were obtained by the Heidelberg Retina Tomograph (HRT), either globally or from predefined disc sectors. In addition to standard parameters, the cup shape measure, an index of depth variation and steepness of the cup walls, was determined. RESULTS: In individual OHT patients, PERG amplitudes at 2.6 cycles/degree were negatively correlated with cup shape measures (r = -0.43, P < 0.01) obtained from analysis of the inferotemporal (IT) sector. No significant correlations were found for the other parameters. On average, the cup shape measures derived from IT sector or global analysis were significantly (P < 0.01) worse, and closer to the measures of EOAG patients, in OHT patients with abnormal PERG compared with those with normal PERGs. The cup shape measure displayed a low sensitivity (20%) and a high specificity (100%) in predicting PERG abnormalities in individual OHT patients. CONCLUSIONS: The results indicate that in OHT there is a significant although weak correlation between PERG amplitude and the shape of the optic disc cup, suggesting a parallel involvement of both function and morphology. Combined PERG and optic disc cup structural analysis is of potential diagnostic value to detect early damage to optic nerve head in individual OHT patients.  (+info)

Isoforms of nitric oxide synthase in the optic nerves of rat eyes with chronic moderately elevated intraocular pressure. (7/803)

PURPOSE: To investigate the hypothesis that nitric oxide (NO) in the optic nerve heads of rats with chronic moderately elevated intraocular pressure (IOP) contributes to neurotoxicity of the retinal ganglion cells, the presence of the three isoforms of nitric oxide synthase (NOS) was determined in the tissue. METHODS: Unilateral chronic moderately elevated IOP was produced in rats by cautery of three episcleral vessels. Histologic sections of optic nerves from eyes with normal IOP and with chronic moderately elevated IOP were studied by immunohistochemistry and by immunoblot analysis. Polyclonal antibodies to NOS-1, NOS-2, NOS-3, and glial fibrillary acidic protein (GFAP) were localized with immunoperoxidase. RESULTS: In the optic nerve of rat eyes with normal IOP, NOS-1 was constitutively present in astrocytes, pericytes and nerve terminals in the walls of the central artery. NOS-2 was not present in eyes with normal IOP. In these eyes, NOS-3 was constitutively present in the vascular endothelia of large and small vessels. Rat eyes treated with three-vessel cautery had sustained elevated IOP (1.6 fold) for at least 3 months. In these eyes, no obvious changes in NOS-1 or NOS-3 were noted. However, at time points as early as 4 days of chronic moderately elevated IOP, NOS-2 appeared in astrocytes in the optic nerve heads of these eyes and persisted for up to 3 months. Immunoblot analysis did not detect differences in NOS isoforms. CONCLUSION: The cellular distributions of constitutive NOS isoforms in the rat optic nerve suggest physiological roles for NO in this tissue. NOS-1 in astrocytes may produce NO as a mediator between neighboring cells. NO, produced by NOS-1 in pericytes and nitrergic nerve terminals and by NOS-3 in vascular endothelia, is probably a physiological vasodilator in this tissue. In eyes with chronic moderately elevated IOP, NOS-2 is apparently induced in astrocytes. The excessive NO production that is associated with this isoform may contribute to the neurotoxicity of the retinal ganglion cells in eyes with chronic moderately elevated IOP.  (+info)

Comparison of the intraocular pressure lowering effect of latanoprost and a fixed combination of timolol-pilocarpine eye drops in patients insufficiently controlled with beta adrenergic antagonists. French Latanoprost Study Group, and the Swedish Latanoprost Study Group. (8/803)

AIMS: To compare the effect on intraocular pressure (IOP) of latanoprost monotherapy and timolol-pilocarpine in patients with glaucoma or ocular hypertension with inadequately controlled IOP on topical beta adrenergic antagonists. METHODS: This was a multicentre, randomised, observer masked, 6 week study performed in France and Sweden. 23 centres enrolled 237 patients with glaucoma or ocular hypertension and an IOP of at least 22 mm Hg on treatment with topical beta adrenergic antagonists, alone or in combination. After a 21 day run in period on timolol 0.5% twice daily, patients were randomised either to latanoprost 0.005% once daily or to a fixed combination of timolol-pilocarpine twice daily. Changes in mean diurnal IOP from the baseline to the 6 week visit were determined with an analysis of covariance. RESULTS: Mean diurnal IOP was statistically significantly decreased from baseline in both groups (p<0.001). Switching to latanoprost treatment reduced mean diurnal IOP by 5.4 (SEM 0.3) mm Hg (ANCOVA -22%) and switching to timolol-pilocarpine treatment reduced mean diurnal IOP by 4.9 (0.4) mm Hg (-20%). Blurred vision, decreased visual acuity, decreased twilight vision, and headache were statistically significantly more frequent in the timolol-pilocarpine group. CONCLUSIONS: Latanoprost monotherapy was at least as effective as fixed combination timolol-pilocarpine twice daily treatment in reducing mean diurnal IOP in patients not adequately controlled on topical beta adrenergic antagonists. Latanoprost was better tolerated than timolol-pilocarpine regarding side effects. These results indicate that a switch to latanoprost monotherapy can be attempted before combination therapy is initiated.  (+info)

Ocular hypertension is a medical condition characterized by elevated pressure within the eye (intraocular pressure or IOP), which is higher than normal but not necessarily high enough to cause any visible damage to the optic nerve or visual field loss. It serves as a significant risk factor for developing glaucoma, a sight-threatening disease.

The normal range of intraocular pressure is typically between 10-21 mmHg (millimeters of mercury). Ocular hypertension is often defined as an IOP consistently above 21 mmHg, although some studies suggest that even pressures between 22-30 mmHg may not cause damage in all individuals. Regular monitoring and follow-up with an ophthalmologist are essential for people diagnosed with ocular hypertension to ensure early detection and management of any potential glaucomatous changes. Treatment options include medications, laser therapy, or surgery to lower the IOP and reduce the risk of glaucoma onset.

Intraocular pressure (IOP) is the fluid pressure within the eye, specifically within the anterior chamber, which is the space between the cornea and the iris. It is measured in millimeters of mercury (mmHg). The aqueous humor, a clear fluid that fills the anterior chamber, is constantly produced and drained, maintaining a balance that determines the IOP. Normal IOP ranges from 10-21 mmHg, with average values around 15-16 mmHg. Elevated IOP is a key risk factor for glaucoma, a group of eye conditions that can lead to optic nerve damage and vision loss if not treated promptly and effectively. Regular monitoring of IOP is essential in diagnosing and managing glaucoma and other ocular health issues.

Open-angle glaucoma is a chronic, progressive type of glaucoma characterized by the gradual loss of optic nerve fibers and resulting in visual field defects. It is called "open-angle" because the angle where the iris meets the cornea (trabecular meshwork) appears to be normal and open on examination. The exact cause of this condition is not fully understood, but it is associated with increased resistance to the outflow of aqueous humor within the trabecular meshwork, leading to an increase in intraocular pressure (IOP). This elevated IOP can cause damage to the optic nerve and result in vision loss.

The onset of open-angle glaucoma is often asymptomatic, making regular comprehensive eye examinations crucial for early detection and management. Treatment typically involves lowering IOP using medications, laser therapy, or surgery to prevent further optic nerve damage and preserve vision.

Glaucoma is a group of eye conditions that damage the optic nerve, often caused by an abnormally high pressure in the eye (intraocular pressure). This damage can lead to permanent vision loss or even blindness if left untreated. The most common type is open-angle glaucoma, which has no warning signs and progresses slowly. Angle-closure glaucoma, on the other hand, can cause sudden eye pain, redness, nausea, and vomiting, as well as rapid vision loss. Other less common types of glaucoma also exist. While there is no cure for glaucoma, early detection and treatment can help slow or prevent further vision loss.

Prostaglandins F (PGF) are a type of prostaglandin, which are naturally occurring hormone-like substances that have various effects on the body. They are produced in response to injury or infection and play a role in inflammation, fever, and pain. Prostaglandins F are synthesized for medical use and are available as drugs known as dinoprost and cloprostenol.

Dinoprost is a synthetic form of PGF2α (prostaglandin F2 alpha) used to induce labor and treat postpartum hemorrhage. It works by causing the uterus to contract, helping to expel the placenta and reduce bleeding.

Cloprostenol is a synthetic form of PGF2α used in veterinary medicine as a reproductive hormone to synchronize estrus cycles in cattle and sheep, as well as to induce parturition (giving birth) in cows. It works by stimulating the contraction of the uterus and promoting the release of luteinizing hormone (LH), which triggers ovulation.

It is important to note that these synthetic prostaglandins should only be used under the supervision of a healthcare professional or veterinarian, as they can have side effects and interactions with other medications.

Hypertension is a medical term used to describe abnormally high blood pressure in the arteries, often defined as consistently having systolic blood pressure (the top number in a blood pressure reading) over 130 mmHg and/or diastolic blood pressure (the bottom number) over 80 mmHg. It is also commonly referred to as high blood pressure.

Hypertension can be classified into two types: primary or essential hypertension, which has no identifiable cause and accounts for about 95% of cases, and secondary hypertension, which is caused by underlying medical conditions such as kidney disease, hormonal disorders, or use of certain medications.

If left untreated, hypertension can lead to serious health complications such as heart attack, stroke, heart failure, and chronic kidney disease. Therefore, it is important for individuals with hypertension to manage their condition through lifestyle modifications (such as healthy diet, regular exercise, stress management) and medication if necessary, under the guidance of a healthcare professional.

Ocular tonometry is a medical test used to measure the pressure inside the eye, also known as intraocular pressure (IOP). This test is an essential part of diagnosing and monitoring glaucoma, a group of eye conditions that can cause vision loss and blindness due to damage to the optic nerve from high IOP.

The most common method of ocular tonometry involves using a tonometer device that gently touches the front surface of the eye (cornea) with a small probe or prism. The device measures the amount of force required to flatten the cornea slightly, which correlates with the pressure inside the eye. Other methods of ocular tonometry include applanation tonometry, which uses a small amount of fluorescein dye and a blue light to measure the IOP, and rebound tonometry, which uses a lightweight probe that briefly touches the cornea and then bounces back to determine the IOP.

Regular ocular tonometry is important for detecting glaucoma early and preventing vision loss. It is typically performed during routine eye exams and may be recommended more frequently for individuals at higher risk of developing glaucoma, such as those with a family history of the condition or certain medical conditions like diabetes.

Timolol is a non-selective beta blocker drug that is primarily used to treat hypertension, angina pectoris, and glaucoma. It works by blocking the action of certain hormones such as epinephrine (adrenaline) on the heart and blood vessels, which helps to lower heart rate, reduce the force of heart muscle contraction, and decrease blood vessel constriction. These effects can help to lower blood pressure, reduce the workload on the heart, and improve oxygen supply to the heart muscle. In glaucoma treatment, timolol reduces the production of aqueous humor in the eye, thereby decreasing intraocular pressure.

The medical definition of Timolol is:

Timolol (tim-oh-lol) is a beta-adrenergic receptor antagonist used to treat hypertension, angina pectoris, and glaucoma. It works by blocking the action of epinephrine on the heart and blood vessels, which results in decreased heart rate, reduced force of heart muscle contraction, and decreased blood vessel constriction. In glaucoma treatment, timolol reduces aqueous humor production, thereby decreasing intraocular pressure. Timolol is available as an oral tablet, solution for injection, and ophthalmic solution.

Pulmonary hypertension is a medical condition characterized by increased blood pressure in the pulmonary arteries, which are the blood vessels that carry blood from the right side of the heart to the lungs. This results in higher than normal pressures in the pulmonary circulation and can lead to various symptoms and complications.

Pulmonary hypertension is typically defined as a mean pulmonary artery pressure (mPAP) greater than or equal to 25 mmHg at rest, as measured by right heart catheterization. The World Health Organization (WHO) classifies pulmonary hypertension into five groups based on the underlying cause:

1. Pulmonary arterial hypertension (PAH): This group includes idiopathic PAH, heritable PAH, drug-induced PAH, and associated PAH due to conditions such as connective tissue diseases, HIV infection, portal hypertension, congenital heart disease, and schistosomiasis.
2. Pulmonary hypertension due to left heart disease: This group includes conditions that cause elevated left atrial pressure, such as left ventricular systolic or diastolic dysfunction, valvular heart disease, and congenital cardiovascular shunts.
3. Pulmonary hypertension due to lung diseases and/or hypoxia: This group includes chronic obstructive pulmonary disease (COPD), interstitial lung disease, sleep-disordered breathing, alveolar hypoventilation disorders, and high altitude exposure.
4. Chronic thromboembolic pulmonary hypertension (CTEPH): This group includes persistent obstruction of the pulmonary arteries due to organized thrombi or emboli.
5. Pulmonary hypertension with unclear and/or multifactorial mechanisms: This group includes hematologic disorders, systemic disorders, metabolic disorders, and other conditions that can cause pulmonary hypertension but do not fit into the previous groups.

Symptoms of pulmonary hypertension may include shortness of breath, fatigue, chest pain, lightheadedness, and syncope (fainting). Diagnosis typically involves a combination of medical history, physical examination, imaging studies, and invasive testing such as right heart catheterization. Treatment depends on the underlying cause but may include medications, oxygen therapy, pulmonary rehabilitation, and, in some cases, surgical intervention.

Antihypertensive agents are a class of medications used to treat high blood pressure (hypertension). They work by reducing the force and rate of heart contractions, dilating blood vessels, or altering neurohormonal activation to lower blood pressure. Examples include diuretics, beta blockers, ACE inhibitors, ARBs, calcium channel blockers, and direct vasodilators. These medications may be used alone or in combination to achieve optimal blood pressure control.

The optic disk, also known as the optic nerve head, is the point where the optic nerve fibers exit the eye and transmit visual information to the brain. It appears as a pale, circular area in the back of the eye, near the center of the retina. The optic disk has no photoreceptor cells (rods and cones), so it is insensitive to light. It is an important structure to observe during eye examinations because changes in its appearance can indicate various ocular diseases or conditions, such as glaucoma, optic neuritis, or papilledema.

Cloprostenol is a synthetic prostaglandin analog used primarily in veterinary medicine for the treatment and prevention of various conditions. The main therapeutic uses of Cloprostenol include:

1. Induction of parturition (labor) in cows, helping to synchronize calving in managed herds.
2. Termination of pregnancy in cattle, especially in cases where the fetus is nonviable or the pregnancy poses a risk to the animal's health.
3. Treatment of uterine and oviductal disorders, such as pyometra (infection of the uterus) and salpingitis (inflammation of the oviduct), in cattle and pigs.
4. Prevention of postpartum disorders, like endometritis (inflammation of the lining of the uterus) and mastitis (inflammation of the mammary glands), by promoting uterine involution and improving overall reproductive performance in cattle.
5. Control of estrus (heat) in cattle, as an aid in estrous synchronization programs for artificial insemination.

Cloprostenol is available in various formulations, such as intramuscular or subcutaneous injectable solutions, and is typically administered by a veterinarian or trained personnel. It is important to note that the use of Cloprostenol and other prostaglandin analogs should be carried out under the guidance and supervision of a veterinary professional, as improper usage can lead to adverse effects or complications.

Optic nerve diseases refer to a group of conditions that affect the optic nerve, which transmits visual information from the eye to the brain. These diseases can cause various symptoms such as vision loss, decreased visual acuity, changes in color vision, and visual field defects. Examples of optic nerve diseases include optic neuritis (inflammation of the optic nerve), glaucoma (damage to the optic nerve due to high eye pressure), optic nerve damage from trauma or injury, ischemic optic neuropathy (lack of blood flow to the optic nerve), and optic nerve tumors. Treatment for optic nerve diseases varies depending on the specific condition and may include medications, surgery, or lifestyle changes.

Visual fields refer to the total area in which objects can be seen while keeping the eyes focused on a central point. It is the entire area that can be observed using peripheral (side) vision while the eye gazes at a fixed point. A visual field test is used to detect blind spots or gaps (scotomas) in a person's vision, which could indicate various medical conditions such as glaucoma, retinal damage, optic nerve disease, brain tumors, or strokes. The test measures both the central and peripheral vision and maps the entire area that can be seen when focusing on a single point.

Ophthalmic solutions are sterile, single-use or multi-dose preparations in a liquid form that are intended for topical administration to the eye. These solutions can contain various types of medications, such as antibiotics, anti-inflammatory agents, antihistamines, or lubricants, which are used to treat or prevent ocular diseases and conditions.

The pH and osmolarity of ophthalmic solutions are carefully controlled to match the physiological environment of the eye and minimize any potential discomfort or irritation. The solutions may be packaged in various forms, including drops, sprays, or irrigations, depending on the intended use and administration route.

It is important to follow the instructions for use provided by a healthcare professional when administering ophthalmic solutions, as improper use can lead to eye injury or reduced effectiveness of the medication.

A visual field test is a method used to measure an individual's entire scope of vision, which includes what can be seen straight ahead and in peripheral (or side) vision. During the test, the person being tested is asked to focus on a central point while gradually identifying the appearance of objects moving into their peripheral vision. The visual field test helps detect blind spots (scotomas) or gaps in the visual field, which can be caused by various conditions such as glaucoma, brain injury, optic nerve damage, or retinal disorders. It's an essential tool for diagnosing and monitoring eye-related diseases and conditions.

Pharmaceutical preservatives are substances that are added to medications, pharmaceutical products, or biological specimens to prevent degradation, contamination, or spoilage caused by microbial growth, chemical reactions, or environmental factors. These preservatives help extend the shelf life and ensure the stability, safety, and efficacy of the pharmaceutical formulation during storage and use.

Commonly used pharmaceutical preservatives include:

1. Antimicrobials: These are further classified into antifungals (e.g., benzalkonium chloride, chlorhexidine, thimerosal), antibacterials (e.g., parabens, phenol, benzyl alcohol), and antivirals (e.g., phenolic compounds). They work by inhibiting the growth of microorganisms like bacteria, fungi, and viruses.
2. Antioxidants: These substances prevent or slow down oxidation reactions that can degrade pharmaceutical products. Examples include ascorbic acid (vitamin C), tocopherols (vitamin E), sulfites, and butylated hydroxyanisole (BHA) and butylated hydroxytoluene (BHT).
3. Chelating agents: These bind to metal ions that can catalyze degradation reactions in pharmaceutical products. Ethylenediaminetetraacetic acid (EDTA) is an example of a chelating agent used in pharmaceuticals.

The choice of preservative depends on the type of formulation, route of administration, and desired shelf life. The concentration of the preservative should be optimized to maintain product stability while minimizing potential toxicity or adverse effects. It is essential to conduct thorough safety and compatibility studies before incorporating any preservative into a pharmaceutical formulation.

The trabecular meshwork is a specialized tissue located in the anterior chamber angle of the eye, near the iris and cornea. It is composed of a network of interconnected beams or trabeculae that provide support and structure to the eye. The primary function of the trabecular meshwork is to regulate the outflow of aqueous humor, the fluid that fills the anterior chamber of the eye, and maintain intraocular pressure within normal ranges.

The aqueous humor flows from the ciliary processes in the posterior chamber of the eye through the pupil and into the anterior chamber. From there, it drains out of the eye through the trabecular meshwork and into the canal of Schlemm, which leads to the venous system. Any obstruction or damage to the trabecular meshwork can lead to an increase in intraocular pressure and potentially contribute to the development of glaucoma, a leading cause of irreversible blindness worldwide.

Retinal Ganglion Cells (RGCs) are a type of neuron located in the innermost layer of the retina, the light-sensitive tissue at the back of the eye. These cells receive visual information from photoreceptors (rods and cones) via intermediate cells called bipolar cells. RGCs then send this visual information through their long axons to form the optic nerve, which transmits the signals to the brain for processing and interpretation as vision.

There are several types of RGCs, each with distinct morphological and functional characteristics. Some RGCs are specialized in detecting specific features of the visual scene, such as motion, contrast, color, or brightness. The diversity of RGCs allows for a rich and complex representation of the visual world in the brain.

Damage to RGCs can lead to various visual impairments, including loss of vision, reduced visual acuity, and altered visual fields. Conditions associated with RGC damage or degeneration include glaucoma, optic neuritis, ischemic optic neuropathy, and some inherited retinal diseases.

Synthetic prostaglandins are human-made versions of prostaglandins, which are naturally occurring hormone-like substances in the body that play many roles in health and disease. Prostaglandins are produced in various tissues throughout the body and have diverse effects, such as regulating blood flow, promoting inflammation, causing muscle contraction or relaxation, and modulating pain perception.

Synthetic prostaglandins are developed to mimic the effects of natural prostaglandins and are used for therapeutic purposes in medical treatments. They can be chemically synthesized or derived from animal tissues. Synthetic prostaglandins have been used in various clinical settings, including:

1. Induction of labor: Synthetic prostaglandin E1 (dinoprostone) and prostaglandin E2 (misoprostol) are used to ripen the cervix and induce labor in pregnant women.
2. Abortion: Misoprostol is used off-label for early pregnancy termination, often in combination with mifepristone.
3. Prevention of nonsteroidal anti-inflammatory drug (NSAID)-induced gastric ulcers: Misoprostol is sometimes prescribed to protect the stomach lining from developing ulcers due to long-term NSAID use.
4. Treatment of postpartum hemorrhage: Synthetic prostaglandins like carboprost (15-methyl prostaglandin F2α) and dinoprostone are used to manage severe bleeding after childbirth.
5. Management of dysmenorrhea: Misoprostol is sometimes prescribed for the treatment of painful periods or menstrual cramps.
6. Treatment of erectile dysfunction: Alprostadil, a synthetic prostaglandin E1, can be used as an intracavernosal injection or urethral suppository to treat erectile dysfunction.

It is important to note that while synthetic prostaglandins mimic the effects of natural prostaglandins, they may also have additional or different properties and potential side effects. Therefore, their use should be under the guidance and supervision of a healthcare professional.

Aqueous humor is a clear, watery fluid that fills the anterior and posterior chambers of the eye. It is produced by the ciliary processes in the posterior chamber and circulates through the pupil into the anterior chamber, where it provides nutrients to the cornea and lens, maintains intraocular pressure, and helps to shape the eye. The aqueous humor then drains out of the eye through the trabecular meshwork and into the canal of Schlemm, eventually reaching the venous system.

Renal hypertension, also known as renovascular hypertension, is a type of secondary hypertension (high blood pressure) that is caused by narrowing or obstruction of the renal arteries or veins, which supply blood to the kidneys. This can lead to decreased blood flow and oxygen delivery to the kidney tissue, activating the renin-angiotensin-aldosterone system (RAAS) and resulting in increased peripheral vascular resistance, sodium retention, and extracellular fluid volume, ultimately causing hypertension.

Renal hypertension can be classified into two types:

1. Renin-dependent renal hypertension: This is caused by a decrease in blood flow to the kidneys, leading to increased renin release from the juxtaglomerular cells of the kidney. Renin converts angiotensinogen to angiotensin I, which is then converted to angiotensin II by angiotensin-converting enzyme (ACE). Angiotensin II is a potent vasoconstrictor that causes an increase in peripheral vascular resistance and blood pressure.
2. Renin-independent renal hypertension: This is caused by increased sodium retention and extracellular fluid volume, leading to an increase in blood pressure. This can be due to various factors such as obstructive sleep apnea, primary aldosteronism, or pheochromocytoma.

Renal hypertension is often asymptomatic but can lead to serious complications such as kidney damage, heart failure, and stroke if left untreated. Diagnosis of renal hypertension involves imaging studies such as renal artery duplex ultrasound, CT angiography, or magnetic resonance angiography (MRA) to identify any narrowing or obstruction in the renal arteries or veins. Treatment options include medications such as ACE inhibitors, angiotensin receptor blockers (ARBs), calcium channel blockers, and diuretics, as well as interventions such as angioplasty and stenting to improve blood flow to the kidneys.

Vision disorders refer to a wide range of conditions that affect the visual system and result in various symptoms, such as blurry vision, double vision, distorted vision, impaired depth perception, and difficulty with visual tracking or focusing. These disorders can be categorized into several types, including:

1. Refractive errors: These occur when the shape of the eye prevents light from focusing directly on the retina, resulting in blurry vision. Examples include myopia (nearsightedness), hyperopia (farsightedness), astigmatism, and presbyopia (age-related loss of near vision).
2. Strabismus: Also known as crossed eyes or walleye, strabismus is a misalignment of the eyes where they point in different directions, which can lead to double vision or loss of depth perception.
3. Amblyopia: Often called lazy eye, amblyopia is a condition where one eye has reduced vision due to lack of proper visual development during childhood. It may be caused by strabismus, refractive errors, or other factors that interfere with normal visual development.
4. Accommodative disorders: These involve problems with the focusing ability of the eyes, such as convergence insufficiency (difficulty focusing on close objects) and accommodative dysfunction (inability to maintain clear vision at different distances).
5. Binocular vision disorders: These affect how the eyes work together as a team, leading to issues like poor depth perception, eye strain, and headaches. Examples include convergence insufficiency, divergence excess, and suppression.
6. Ocular motility disorders: These involve problems with eye movement, such as nystagmus (involuntary eye movements), strabismus, or restricted extraocular muscle function.
7. Visual processing disorders: These affect the brain's ability to interpret and make sense of visual information, even when the eyes themselves are healthy. Symptoms may include difficulty with reading, recognizing shapes and objects, and understanding spatial relationships.
8. Low vision: This term refers to significant visual impairment that cannot be fully corrected with glasses, contact lenses, medication, or surgery. It includes conditions like macular degeneration, diabetic retinopathy, glaucoma, and cataracts.
9. Blindness: Complete loss of sight in both eyes, which can be caused by various factors such as injury, disease, or genetic conditions.

Blood pressure is the force exerted by circulating blood on the walls of the blood vessels. It is measured in millimeters of mercury (mmHg) and is given as two figures:

1. Systolic pressure: This is the pressure when the heart pushes blood out into the arteries.
2. Diastolic pressure: This is the pressure when the heart rests between beats, allowing it to fill with blood.

Normal blood pressure for adults is typically around 120/80 mmHg, although this can vary slightly depending on age, sex, and other factors. High blood pressure (hypertension) is generally considered to be a reading of 130/80 mmHg or higher, while low blood pressure (hypotension) is usually defined as a reading below 90/60 mmHg. It's important to note that blood pressure can fluctuate throughout the day and may be affected by factors such as stress, physical activity, and medication use.

Topical administration refers to a route of administering a medication or treatment directly to a specific area of the body, such as the skin, mucous membranes, or eyes. This method allows the drug to be applied directly to the site where it is needed, which can increase its effectiveness and reduce potential side effects compared to systemic administration (taking the medication by mouth or injecting it into a vein or muscle).

Topical medications come in various forms, including creams, ointments, gels, lotions, solutions, sprays, and patches. They may be used to treat localized conditions such as skin infections, rashes, inflammation, or pain, or to deliver medication to the eyes or mucous membranes for local or systemic effects.

When applying topical medications, it is important to follow the instructions carefully to ensure proper absorption and avoid irritation or other adverse reactions. This may include cleaning the area before application, covering the treated area with a dressing, or avoiding exposure to sunlight or water after application, depending on the specific medication and its intended use.

Portal hypertension is a medical condition characterized by an increased pressure in the portal vein, which is the large blood vessel that carries blood from the intestines, spleen, and pancreas to the liver. Normal portal venous pressure is approximately 5-10 mmHg. Portal hypertension is defined as a portal venous pressure greater than 10 mmHg.

The most common cause of portal hypertension is cirrhosis of the liver, which leads to scarring and narrowing of the small blood vessels in the liver, resulting in increased resistance to blood flow. Other causes include blood clots in the portal vein, inflammation of the liver or bile ducts, and invasive tumors that block the flow of blood through the liver.

Portal hypertension can lead to a number of complications, including the development of abnormal blood vessels (varices) in the esophagus, stomach, and intestines, which are prone to bleeding. Ascites, or the accumulation of fluid in the abdominal cavity, is another common complication of portal hypertension. Other potential complications include encephalopathy, which is a condition characterized by confusion, disorientation, and other neurological symptoms, and an increased risk of bacterial infections.

Treatment of portal hypertension depends on the underlying cause and the severity of the condition. Medications to reduce pressure in the portal vein, such as beta blockers or nitrates, may be used. Endoscopic procedures to band or inject varices can help prevent bleeding. In severe cases, surgery or liver transplantation may be necessary.

Miotics, also known as parasympathomimetics or cholinergic agents, are a class of medications that stimulate the parasympathetic nervous system. They work by activating muscarinic receptors, which are found in various organs throughout the body, including the eye. In the eye, miotics cause contraction of the circular muscle of the iris, resulting in pupillary constriction (miosis). This action can help to reduce intraocular pressure in patients with glaucoma.

Miotics may also have other effects on the eye, such as accommodation (focusing) and decreasing the production of aqueous humor. Some examples of miotics include pilocarpine, carbachol, and ecothiopate. It's important to note that the use of miotics can have side effects, including blurred vision, headache, and brow ache.

Levobunolol is a non-selective beta blocker used in the treatment of glaucoma and high blood pressure. It works by reducing the production of aqueous humor within the eye, thereby decreasing intraocular pressure (IOP). Levobunolol is available as an ophthalmic solution for topical application.

The medical definition of Levobunolol is:

A synthetic, non-selective beta-adrenergic antagonist with membrane-stabilizing activity and a vasodilating effect. It is used in the form of its hydrochloride salt as an ophthalmic solution for the treatment of glaucoma, reducing intraocular pressure by decreasing aqueous humor production. The drug has a prolonged action due to its poor solubility and slow absorption through the cornea.

The eye is the organ of sight, primarily responsible for detecting and focusing on visual stimuli. It is a complex structure composed of various parts that work together to enable vision. Here are some of the main components of the eye:

1. Cornea: The clear front part of the eye that refracts light entering the eye and protects the eye from harmful particles and microorganisms.
2. Iris: The colored part of the eye that controls the amount of light reaching the retina by adjusting the size of the pupil.
3. Pupil: The opening in the center of the iris that allows light to enter the eye.
4. Lens: A biconvex structure located behind the iris that further refracts light and focuses it onto the retina.
5. Retina: A layer of light-sensitive cells (rods and cones) at the back of the eye that convert light into electrical signals, which are then transmitted to the brain via the optic nerve.
6. Optic Nerve: The nerve that carries visual information from the retina to the brain.
7. Vitreous: A clear, gel-like substance that fills the space between the lens and the retina, providing structural support to the eye.
8. Conjunctiva: A thin, transparent membrane that covers the front of the eye and the inner surface of the eyelids.
9. Extraocular Muscles: Six muscles that control the movement of the eye, allowing for proper alignment and focus.

The eye is a remarkable organ that allows us to perceive and interact with our surroundings. Various medical specialties, such as ophthalmology and optometry, are dedicated to the diagnosis, treatment, and management of various eye conditions and diseases.

Electroretinography (ERG) is a medical test used to evaluate the functioning of the retina, which is the light-sensitive tissue located at the back of the eye. The test measures the electrical responses of the retina to light stimulation.

During the procedure, a special contact lens or electrode is placed on the surface of the eye to record the electrical activity generated by the retina's light-sensitive cells (rods and cones) and other cells in the retina. The test typically involves presenting different levels of flashes of light to the eye while the electrical responses are recorded.

The resulting ERG waveform provides information about the overall health and function of the retina, including the condition of the photoreceptors, the integrity of the inner retinal layers, and the health of the retinal ganglion cells. This test is often used to diagnose and monitor various retinal disorders, such as retinitis pigmentosa, macular degeneration, and diabetic retinopathy.

The anterior chamber is the front portion of the eye, located between the cornea (the clear front "window" of the eye) and the iris (the colored part of the eye). It is filled with a clear fluid called aqueous humor that provides nutrients to the structures inside the eye and helps maintain its shape. The anterior chamber plays an important role in maintaining the overall health and function of the eye.

Ophthalmic administration refers to the application or delivery of medications directly into the eye or on the surface of the eye. This route is commonly used for treating various eye conditions such as infections, inflammation, or glaucoma. The medication can be administered in several ways, including:

1. Eye drops: A liquid solution that is instilled into the lower conjunctival sac (the space between the eyeball and the lower eyelid) using a dropper. The patient should be advised to tilt their head back, look up, and pull down the lower eyelid to create a pocket for the drop.
2. Eye ointment: A semi-solid preparation that is applied to the lower conjunctival sac or the edge of the eyelid using a small tube or applicator. Ointments provide a longer contact time with the eye surface compared to eye drops, making them suitable for nighttime use or treating conditions that require prolonged medication exposure.
3. Eye inserts or pellets: Slow-release devices that contain medications and are placed either in the conjunctival sac or on the surface of the eye. These inserts gradually dissolve, releasing the active ingredient over an extended period.
4. Eye patches or bandages: In some cases, medication may be applied to an eye patch or bandage, which is then placed over the affected eye. This method is less common and typically used when other forms of administration are not feasible.

When administering ophthalmic medications, it's essential to follow proper techniques to ensure the correct dosage reaches the target area and minimize systemic absorption. Patients should also be advised about potential side effects, precautions, and storage requirements for their specific medication.

Renovascular hypertension is a type of secondary hypertension (high blood pressure) that is caused by renal artery stenosis or narrowing. This condition reduces blood flow to the kidneys, leading to the activation of the renin-angiotensin-aldosterone system (RAAS), which causes an increase in peripheral vascular resistance and blood volume, resulting in hypertension.

Renovascular hypertension is often seen in people with atherosclerosis or fibromuscular dysplasia, which are the most common causes of renal artery stenosis. Other conditions that can lead to renovascular hypertension include vasculitis, blood clots, and compression of the renal artery by nearby structures.

Diagnosis of renovascular hypertension typically involves imaging studies such as duplex ultrasound, CT angiography, or magnetic resonance angiography to visualize the renal arteries and assess for stenosis. Treatment may involve medications to control blood pressure, lifestyle modifications, and procedures such as angioplasty and stenting to open up the narrowed renal artery. In some cases, surgery may be necessary to restore blood flow to the kidney.

The optic nerve, also known as the second cranial nerve, is the nerve that transmits visual information from the retina to the brain. It is composed of approximately one million nerve fibers that carry signals related to vision, such as light intensity and color, from the eye's photoreceptor cells (rods and cones) to the visual cortex in the brain. The optic nerve is responsible for carrying this visual information so that it can be processed and interpreted by the brain, allowing us to see and perceive our surroundings. Damage to the optic nerve can result in vision loss or impairment.

Gonioscopy is a diagnostic procedure in ophthalmology used to examine the anterior chamber angle, which is the area where the iris and cornea meet. This examination helps to evaluate the drainage pathways of the eye for conditions such as glaucoma. A special contact lens called a goniolens is placed on the cornea during the procedure to allow the healthcare provider to visualize the angle using a biomicroscope. The lens may be coupled with a mirrored or prismatic surface to enhance the view of the angle. Gonioscopy can help detect conditions like narrow angles, closed angles, neovascularization, and other abnormalities that might contribute to glaucoma development or progression.

Tomography is a medical imaging technique used to produce cross-sectional images or slices of specific areas of the body. This technique uses various forms of radiation (X-rays, gamma rays) or sound waves (ultrasound) to create detailed images of the internal structures, such as organs, bones, and tissues. Common types of tomography include Computerized Tomography (CT), Positron Emission Tomography (PET), and Magnetic Resonance Imaging (MRI). The primary advantage of tomography is its ability to provide clear and detailed images of internal structures, allowing healthcare professionals to accurately diagnose and monitor a wide range of medical conditions.

Ophthalmoscopy is a medical examination technique used by healthcare professionals to observe the interior structures of the eye, including the retina, optic disc, and vitreous humor. This procedure typically involves using an ophthalmoscope, a handheld device that consists of a light and magnifying lenses. The healthcare provider looks through the ophthalmoscope and directly observes the internal structures of the eye by illuminating them.

There are several types of ophthalmoscopy, including direct ophthalmoscopy, indirect ophthalmoscopy, and slit-lamp biomicroscopy. Each type has its own advantages and disadvantages, and they may be used in different situations depending on the specific clinical situation and the information needed.

Ophthalmoscopy is an important diagnostic tool for detecting and monitoring a wide range of eye conditions, including diabetic retinopathy, glaucoma, age-related macular degeneration, and other retinal disorders. It can also provide valuable information about the overall health of the individual, as changes in the appearance of the retina or optic nerve may indicate the presence of systemic diseases such as hypertension or diabetes.

Conjunctival diseases refer to a group of medical conditions that affect the conjunctiva, which is the thin, clear mucous membrane that covers the inner surface of the eyelids and the white part of the eye (known as the sclera). The conjunctiva helps to keep the eye moist and protected from irritants.

Conjunctival diseases can cause a range of symptoms, including redness, itching, burning, discharge, grittiness, and pain. Some common conjunctival diseases include:

1. Conjunctivitis (pink eye): This is an inflammation or infection of the conjunctiva that can be caused by viruses, bacteria, or allergies. Symptoms may include redness, itching, discharge, and watery eyes.
2. Pinguecula: This is a yellowish, raised bump that forms on the conjunctiva, usually near the corner of the eye. It is caused by an overgrowth of connective tissue and may be related to sun exposure or dry eye.
3. Pterygium: This is a fleshy growth that extends from the conjunctiva onto the cornea (the clear front part of the eye). It can cause redness, irritation, and vision problems if it grows large enough to cover the pupil.
4. Allergic conjunctivitis: This is an inflammation of the conjunctiva caused by an allergic reaction to substances such as pollen, dust mites, or pet dander. Symptoms may include redness, itching, watery eyes, and swelling.
5. Chemical conjunctivitis: This is an irritation or inflammation of the conjunctiva caused by exposure to chemicals such as chlorine, smoke, or fumes. Symptoms may include redness, burning, and tearing.
6. Giant papillary conjunctivitis (GPC): This is a type of allergic reaction that occurs in response to the presence of a foreign body in the eye, such as a contact lens. Symptoms may include itching, mucus discharge, and a gritty feeling in the eye.

Treatment for conjunctival diseases depends on the underlying cause. In some cases, over-the-counter medications or home remedies may be sufficient to relieve symptoms. However, more severe cases may require prescription medication or medical intervention. It is important to consult with a healthcare provider if you experience persistent or worsening symptoms of conjunctival disease.

I'm sorry for any confusion, but "photography" is not a term typically used in medical definitions. Photography refers to the art, application, or process of creating images by recording light or other electromagnetic radiation, either electronically by means of an image sensor, or chemically by means of a light-sensitive material such as photographic film.

If you're looking for a medical term related to imaging, there are several terms that might be relevant, such as:

1. Radiography: This is a technique using X-rays to visualize the internal structures of the body.
2. Ultrasonography: Also known as ultrasound, this is a diagnostic imaging technique using high-frequency sound waves to create images of the inside of the body.
3. Computed Tomography (CT): A type of imaging that uses X-rays to create detailed cross-sectional images of the body.
4. Magnetic Resonance Imaging (MRI): A type of imaging that uses magnetic fields and radio waves to create detailed images of the organs and tissues within the body.
5. Nuclear Medicine: This is a branch of medical imaging that uses small amounts of radioactive material to diagnose and treat diseases.

If you have any questions related to medical definitions or topics, feel free to ask!

Benzalkonium compounds are a group of related chemicals that have antimicrobial properties. They are commonly used as disinfectants and preservatives in various products such as eye drops, nasal sprays, skin creams, and household cleaners. Benzalkonium compounds work by disrupting the cell membranes of bacteria, fungi, and viruses, leading to their death. They are often used in low concentrations and are generally considered safe for topical use, but they can cause irritation and allergic reactions in some people. Prolonged or frequent use of products containing benzalkonium compounds may also lead to the development of bacterial resistance.

Malignant hypertension is a severe form of hypertension (high blood pressure) that is characterized by extremely high blood pressure readings, typically greater than 180/120 mmHg, along with evidence of damage to one or more organ systems. This condition is considered a medical emergency and requires immediate treatment.

Malignant hypertension can cause rapid and severe damage to various organs in the body, including the brain, heart, kidneys, and eyes. Symptoms may include severe headache, visual disturbances, confusion, shortness of breath, chest pain, nausea, vomiting, seizures, and even coma.

The exact cause of malignant hypertension is not always known, but it can be associated with certain underlying medical conditions such as kidney disease, autoimmune disorders, pregnancy-related complications, or the use of certain medications. Treatment typically involves aggressive blood pressure control using intravenous medications in a hospital setting, along with management of any underlying conditions and prevention of further organ damage.

Animal disease models are specialized animals, typically rodents such as mice or rats, that have been genetically engineered or exposed to certain conditions to develop symptoms and physiological changes similar to those seen in human diseases. These models are used in medical research to study the pathophysiology of diseases, identify potential therapeutic targets, test drug efficacy and safety, and understand disease mechanisms.

The genetic modifications can include knockout or knock-in mutations, transgenic expression of specific genes, or RNA interference techniques. The animals may also be exposed to environmental factors such as chemicals, radiation, or infectious agents to induce the disease state.

Examples of animal disease models include:

1. Mouse models of cancer: Genetically engineered mice that develop various types of tumors, allowing researchers to study cancer initiation, progression, and metastasis.
2. Alzheimer's disease models: Transgenic mice expressing mutant human genes associated with Alzheimer's disease, which exhibit amyloid plaque formation and cognitive decline.
3. Diabetes models: Obese and diabetic mouse strains like the NOD (non-obese diabetic) or db/db mice, used to study the development of type 1 and type 2 diabetes, respectively.
4. Cardiovascular disease models: Atherosclerosis-prone mice, such as ApoE-deficient or LDLR-deficient mice, that develop plaque buildup in their arteries when fed a high-fat diet.
5. Inflammatory bowel disease models: Mice with genetic mutations affecting intestinal barrier function and immune response, such as IL-10 knockout or SAMP1/YitFc mice, which develop colitis.

Animal disease models are essential tools in preclinical research, but it is important to recognize their limitations. Differences between species can affect the translatability of results from animal studies to human patients. Therefore, researchers must carefully consider the choice of model and interpret findings cautiously when applying them to human diseases.

Visual acuity is a measure of the sharpness or clarity of vision. It is usually tested by reading an eye chart from a specific distance, such as 20 feet (6 meters). The standard eye chart used for this purpose is called the Snellen chart, which contains rows of letters that decrease in size as you read down the chart.

Visual acuity is typically expressed as a fraction, with the numerator representing the testing distance and the denominator indicating the smallest line of type that can be read clearly. For example, if a person can read the line on the eye chart that corresponds to a visual acuity of 20/20, it means they have normal vision at 20 feet. If their visual acuity is 20/40, it means they must be as close as 20 feet to see what someone with normal vision can see at 40 feet.

It's important to note that visual acuity is just one aspect of overall vision and does not necessarily reflect other important factors such as peripheral vision, depth perception, color vision, or contrast sensitivity.

Corneal surgery, laser refers to a type of surgical procedure performed on the cornea (the clear, dome-shaped surface at the front of the eye) using a laser. The most common type of laser used in corneal surgery is an excimer laser, which can be used to reshape the cornea and correct refractive errors such as nearsightedness, farsightedness, and astigmatism. This procedure is commonly known as LASIK (Laser-Assisted In Situ Keratomileusis).

Another type of laser corneal surgery is PRK (Photorefractive Keratectomy) which uses a laser to reshape the surface of the cornea. This procedure is typically used for patients who have thin corneas or other conditions that make them ineligible for LASIK.

Additionally, there are other types of laser corneal surgeries such as LASEK (Laser Epithelial Keratomileusis), Epi-LASIK (Epithelial Laser-Assisted Keratomileusis) and SBK (Sub Bowman's Keratomileusis) which are variations of the above procedures.

It is important to note that, as with any surgical procedure, laser corneal surgery has risks and potential complications, including dry eye, infection, and visual symptoms such as glare or halos around lights. It is essential for patients to have a thorough examination and consultation with an ophthalmologist before deciding if laser corneal surgery is the right choice for them.

Instillation, in the context of drug administration, refers to the process of introducing a medication or therapeutic agent into a body cavity or onto a mucous membrane surface using gentle, steady pressure. This is typically done with the help of a device such as an eyedropper, pipette, or catheter. The goal is to ensure that the drug is distributed evenly over the surface or absorbed through the mucous membrane for localized or systemic effects. Instillation can be used for various routes of administration including ocular (eye), nasal, auricular (ear), vaginal, and intra-articular (joint space) among others. The choice of instillation as a route of administration depends on the drug's properties, the desired therapeutic effect, and the patient's overall health status.

The retina is the innermost, light-sensitive layer of tissue in the eye of many vertebrates and some cephalopods. It receives light that has been focused by the cornea and lens, converts it into neural signals, and sends these to the brain via the optic nerve. The retina contains several types of photoreceptor cells including rods (which handle vision in low light) and cones (which are active in bright light and are capable of color vision).

In medical terms, any pathological changes or diseases affecting the retinal structure and function can lead to visual impairment or blindness. Examples include age-related macular degeneration, diabetic retinopathy, retinal detachment, and retinitis pigmentosa among others.

Fluorometholone is a type of corticosteroid medication that is often used in eye drops to treat various inflammatory conditions of the eye, such as allergies, uveitis, and keratitis. It works by reducing inflammation and suppressing the activity of the immune system in the eye.

Fluorometholone has a fluorinated molecule, which makes it more lipophilic (fat-soluble) than some other corticosteroids, allowing it to penetrate the eye tissue more effectively. It is available in various strengths and forms, including solutions and ointments, for topical application to the eye.

As with any medication, fluorometholone can have side effects, such as increased pressure inside the eye (glaucoma), cataracts, and delayed healing of wounds. It is important to follow the instructions of your healthcare provider when using this medication and report any unusual symptoms or concerns promptly.

The anterior eye segment refers to the front portion of the eye, which includes the cornea, iris, ciliary body, and lens. The cornea is the clear, dome-shaped surface at the front of the eye that refracts light entering the eye and provides protection. The iris is the colored part of the eye that controls the amount of light reaching the retina by adjusting the size of the pupil. The ciliary body is a muscle that changes the shape of the lens to focus on objects at different distances. The lens is a transparent structure located behind the iris that further refracts light to provide a clear image. Together, these structures work to focus light onto the retina and enable vision.

Fluorophotometry is a medical diagnostic technique that measures the concentration of fluorescein dye in various tissues, particularly the eye. This technique utilizes a specialized instrument called a fluorophotometer which emits light at a specific wavelength that causes the fluorescein to emit light at a longer wavelength. The intensity of this emitted light is then measured and used to calculate the concentration of fluorescein in the tissue.

Fluorophotometry is often used in ophthalmology to assess the permeability of the blood-retinal barrier, which can be helpful in diagnosing and monitoring conditions such as diabetic retinopathy, age-related macular degeneration, and uveitis. It may also have applications in other medical fields for measuring the concentration of fluorescent markers in various tissues.

The cornea is the clear, dome-shaped surface at the front of the eye. It plays a crucial role in focusing vision. The cornea protects the eye from harmful particles and microorganisms, and it also serves as a barrier against UV light. Its transparency allows light to pass through and get focused onto the retina. The cornea does not contain blood vessels, so it relies on tears and the fluid inside the eye (aqueous humor) for nutrition and oxygen. Any damage or disease that affects its clarity and shape can significantly impact vision and potentially lead to blindness if left untreated.

Diagnostic techniques in ophthalmology refer to the various methods and tests used by eye specialists (ophthalmologists) to examine, evaluate, and diagnose conditions related to the eyes and visual system. Here are some commonly used diagnostic techniques:

1. Visual Acuity Testing: This is a basic test to measure the sharpness of a person's vision. It typically involves reading letters or numbers from an eye chart at a specific distance.
2. Refraction Test: This test helps determine the correct lens prescription for glasses or contact lenses by measuring how light is bent as it passes through the cornea and lens.
3. Slit Lamp Examination: A slit lamp is a microscope that allows an ophthalmologist to examine the structures of the eye, including the cornea, iris, lens, and retina, in great detail.
4. Tonometry: This test measures the pressure inside the eye (intraocular pressure) to detect conditions like glaucoma. Common methods include applanation tonometry and non-contact tonometry.
5. Retinal Imaging: Several techniques are used to capture images of the retina, including fundus photography, fluorescein angiography, and optical coherence tomography (OCT). These tests help diagnose conditions like macular degeneration, diabetic retinopathy, and retinal detachments.
6. Color Vision Testing: This test evaluates a person's ability to distinguish between different colors, which can help detect color vision deficiencies or neurological disorders affecting the visual pathway.
7. Visual Field Testing: This test measures a person's peripheral (or side) vision and can help diagnose conditions like glaucoma, optic nerve damage, or brain injuries.
8. Pupillary Reactions Tests: These tests evaluate how the pupils respond to light and near objects, which can provide information about the condition of the eye's internal structures and the nervous system.
9. Ocular Motility Testing: This test assesses eye movements and alignment, helping diagnose conditions like strabismus (crossed eyes) or nystagmus (involuntary eye movement).
10. Corneal Topography: This non-invasive imaging technique maps the curvature of the cornea, which can help detect irregularities, assess the fit of contact lenses, and plan refractive surgery procedures.

Retinal diseases refer to a group of conditions that affect the retina, which is the light-sensitive tissue located at the back of the eye. The retina is responsible for converting light into electrical signals that are sent to the brain and interpreted as visual images. Retinal diseases can cause vision loss or even blindness, depending on their severity and location in the retina.

Some common retinal diseases include:

1. Age-related macular degeneration (AMD): A progressive disease that affects the central part of the retina called the macula, causing blurred or distorted vision.
2. Diabetic retinopathy: A complication of diabetes that can damage the blood vessels in the retina, leading to vision loss.
3. Retinal detachment: A serious condition where the retina becomes separated from its underlying tissue, requiring immediate medical attention.
4. Macular edema: Swelling or thickening of the macula due to fluid accumulation, which can cause blurred vision.
5. Retinitis pigmentosa: A group of inherited eye disorders that affect the retina's ability to respond to light, causing progressive vision loss.
6. Macular hole: A small break in the macula that can cause distorted or blurry vision.
7. Retinal vein occlusion: Blockage of the retinal veins that can lead to bleeding, swelling, and potential vision loss.

Treatment for retinal diseases varies depending on the specific condition and its severity. Some treatments include medication, laser therapy, surgery, or a combination of these options. Regular eye exams are essential for early detection and treatment of retinal diseases.

Laser coagulation, also known as laser photocoagulation, is a medical procedure that uses a laser to seal or destroy abnormal blood vessels or tissue. The laser produces a concentrated beam of light that can be precisely focused on the target area. When the laser energy is absorbed by the tissue, it causes the temperature to rise, which leads to coagulation (the formation of a clot) or destruction of the tissue.

In ophthalmology, laser coagulation is commonly used to treat conditions such as diabetic retinopathy, age-related macular degeneration, and retinal tears or holes. The procedure can help to seal leaking blood vessels, reduce fluid leakage, and prevent further vision loss. It is usually performed as an outpatient procedure and may be repeated if necessary.

In other medical specialties, laser coagulation may be used to control bleeding, destroy tumors, or remove unwanted tissue. The specific technique and parameters of the laser treatment will depend on the individual patient's needs and the condition being treated.

Thiophenes are organic compounds that contain a heterocyclic ring made up of four carbon atoms and one sulfur atom. The structure of thiophene is similar to benzene, with the benzene ring being replaced by a thiophene ring. Thiophenes are aromatic compounds, which means they have a stable, planar ring structure and delocalized electrons.

Thiophenes can be found in various natural sources such as coal tar, crude oil, and some foods like onions and garlic. They also occur in certain medications, dyes, and pesticides. Some thiophene derivatives have been synthesized and studied for their potential therapeutic uses, including anti-inflammatory, antiviral, and antitumor activities.

In the medical field, thiophenes are used in some pharmaceuticals as building blocks to create drugs with various therapeutic effects. For example, tipepidine, a cough suppressant, contains a thiophene ring. Additionally, some anesthetics and antipsychotic medications also contain thiophene moieties.

It is important to note that while thiophenes themselves are not typically considered medical terms, they play a role in the chemistry of various pharmaceuticals and other medical-related compounds.

Medical Definition:

"Risk factors" are any attribute, characteristic or exposure of an individual that increases the likelihood of developing a disease or injury. They can be divided into modifiable and non-modifiable risk factors. Modifiable risk factors are those that can be changed through lifestyle choices or medical treatment, while non-modifiable risk factors are inherent traits such as age, gender, or genetic predisposition. Examples of modifiable risk factors include smoking, alcohol consumption, physical inactivity, and unhealthy diet, while non-modifiable risk factors include age, sex, and family history. It is important to note that having a risk factor does not guarantee that a person will develop the disease, but rather indicates an increased susceptibility.

In medical terms, the iris refers to the colored portion of the eye that surrounds the pupil. It is a circular structure composed of thin, contractile muscle fibers (radial and circumferential) arranged in a regular pattern. These muscles are controlled by the autonomic nervous system and can adjust the size of the pupil in response to changes in light intensity or emotional arousal. By constricting or dilating the iris, the amount of light entering the eye can be regulated, which helps maintain optimal visual acuity under various lighting conditions.

The color of the iris is determined by the concentration and distribution of melanin pigments within the iris stroma. The iris also contains blood vessels, nerves, and connective tissue that support its structure and function. Anatomically, the iris is continuous with the ciliary body and the choroid, forming part of the uveal tract in the eye.

The vitreous body, also known simply as the vitreous, is the clear, gel-like substance that fills the space between the lens and the retina in the eye. It is composed mainly of water, but also contains collagen fibers, hyaluronic acid, and other proteins. The vitreous helps to maintain the shape of the eye and provides a transparent medium for light to pass through to reach the retina. With age, the vitreous can become more liquefied and may eventually separate from the retina, leading to symptoms such as floaters or flashes of light.

Iris diseases refer to a variety of conditions that affect the iris, which is the colored part of the eye that regulates the amount of light reaching the retina by adjusting the size of the pupil. Some common iris diseases include:

1. Iritis: This is an inflammation of the iris and the adjacent tissues in the eye. It can cause pain, redness, photophobia (sensitivity to light), and blurred vision.
2. Aniridia: A congenital condition characterized by the absence or underdevelopment of the iris. This can lead to decreased visual acuity, sensitivity to light, and an increased risk of glaucoma.
3. Iris cysts: These are fluid-filled sacs that form on the iris. They are usually benign but can cause vision problems if they grow too large or interfere with the function of the eye.
4. Iris melanoma: A rare type of eye cancer that develops in the pigmented cells of the iris. It can cause symptoms such as blurred vision, floaters, and changes in the appearance of the iris.
5. Iridocorneal endothelial syndrome (ICE): A group of rare eye conditions that affect the cornea and the iris. They are characterized by the growth of abnormal tissue on the back surface of the cornea and can lead to vision loss.

It is important to seek medical attention if you experience any symptoms of iris diseases, as early diagnosis and treatment can help prevent complications and preserve your vision.

A trabeculectomy is a surgical procedure performed on the eye to treat glaucoma, an eye condition characterized by increased pressure within the eye that can lead to optic nerve damage and vision loss. The main goal of this operation is to create a new channel for the aqueous humor (the clear fluid inside the eye) to drain out, thus reducing the intraocular pressure (IOP).

During the trabeculectomy procedure, a small flap is made in the sclera (the white part of the eye), and a piece of the trabecular meshwork (a structure inside the eye that helps regulate the flow of aqueous humor) is removed. This opening allows the aqueous humor to bypass the obstructed drainage system and form a bleb, a small blister-like sac on the surface of the eye, which absorbs the fluid and reduces IOP.

The success of trabeculectomy depends on various factors, including the patient's age, type and severity of glaucoma, previous treatments, and overall health. Potential complications may include infection, bleeding, cataract formation, hypotony (abnormally low IOP), or failure to control IOP. Regular follow-up appointments with an ophthalmologist are necessary to monitor the eye's response to the surgery and manage any potential issues that may arise.

The sclera is the tough, white, fibrous outer coating of the eye in humans and other vertebrates, covering about five sixths of the eyeball's surface. It provides protection for the delicate inner structures of the eye and maintains its shape. The sclera is composed mainly of collagen and elastic fiber, making it strong and resilient. Its name comes from the Greek word "skleros," which means hard.

Adrenergic beta-antagonists, also known as beta blockers, are a class of medications that block the effects of adrenaline and noradrenaline (also known as epinephrine and norepinephrine) on beta-adrenergic receptors. These receptors are found in various tissues throughout the body, including the heart, lungs, and blood vessels.

Beta blockers work by binding to these receptors and preventing the activation of certain signaling pathways that lead to increased heart rate, force of heart contractions, and relaxation of blood vessels. As a result, beta blockers can lower blood pressure, reduce heart rate, and decrease the workload on the heart.

Beta blockers are used to treat a variety of medical conditions, including hypertension (high blood pressure), angina (chest pain), heart failure, irregular heart rhythms, migraines, and certain anxiety disorders. Some common examples of beta blockers include metoprolol, atenolol, propranolol, and bisoprolol.

It is important to note that while beta blockers can have many benefits, they can also cause side effects such as fatigue, dizziness, and shortness of breath. Additionally, sudden discontinuation of beta blocker therapy can lead to rebound hypertension or worsening chest pain. Therefore, it is important to follow the dosing instructions provided by a healthcare provider carefully when taking these medications.

The blood-aqueous barrier (BAB) is a specialized structure in the eye that helps regulate the exchange of nutrients, oxygen, and waste products between the bloodstream and the anterior chamber of the eye. It is composed of two main components: the nonpigmented epithelial cells of the ciliary body and the endothelial cells of the iris vasculature.

The nonpigmented epithelial cells of the ciliary body form a tight junction that separates the anterior chamber from the ciliary blood vessels, while the endothelial cells lining the iris blood vessels also have tight junctions that restrict the movement of molecules between the blood and the anterior chamber.

The BAB helps maintain the homeostasis of the anterior chamber by controlling the entry of immune cells and preventing the passage of large molecules, toxins, and pathogens from the bloodstream into the eye. Dysfunction of the BAB can lead to various ocular diseases such as uveitis, glaucoma, and age-related macular degeneration.

Eye proteins, also known as ocular proteins, are specific proteins that are found within the eye and play crucial roles in maintaining proper eye function and health. These proteins can be found in various parts of the eye, including the cornea, iris, lens, retina, and other structures. They perform a wide range of functions, such as:

1. Structural support: Proteins like collagen and elastin provide strength and flexibility to the eye's tissues, enabling them to maintain their shape and withstand mechanical stress.
2. Light absorption and transmission: Proteins like opsins and crystallins are involved in capturing and transmitting light signals within the eye, which is essential for vision.
3. Protection against damage: Some eye proteins, such as antioxidant enzymes and heat shock proteins, help protect the eye from oxidative stress, UV radiation, and other environmental factors that can cause damage.
4. Regulation of eye growth and development: Various growth factors and signaling molecules, which are protein-based, contribute to the proper growth, differentiation, and maintenance of eye tissues during embryonic development and throughout adulthood.
5. Immune defense: Proteins involved in the immune response, such as complement components and immunoglobulins, help protect the eye from infection and inflammation.
6. Maintenance of transparency: Crystallin proteins in the lens maintain its transparency, allowing light to pass through unobstructed for clear vision.
7. Neuroprotection: Certain eye proteins, like brain-derived neurotrophic factor (BDNF), support the survival and function of neurons within the retina, helping to preserve vision.

Dysfunction or damage to these eye proteins can contribute to various eye disorders and diseases, such as cataracts, age-related macular degeneration, glaucoma, diabetic retinopathy, and others.

Prospective studies, also known as longitudinal studies, are a type of cohort study in which data is collected forward in time, following a group of individuals who share a common characteristic or exposure over a period of time. The researchers clearly define the study population and exposure of interest at the beginning of the study and follow up with the participants to determine the outcomes that develop over time. This type of study design allows for the investigation of causal relationships between exposures and outcomes, as well as the identification of risk factors and the estimation of disease incidence rates. Prospective studies are particularly useful in epidemiology and medical research when studying diseases with long latency periods or rare outcomes.

Follow-up studies are a type of longitudinal research that involve repeated observations or measurements of the same variables over a period of time, in order to understand their long-term effects or outcomes. In medical context, follow-up studies are often used to evaluate the safety and efficacy of medical treatments, interventions, or procedures.

In a typical follow-up study, a group of individuals (called a cohort) who have received a particular treatment or intervention are identified and then followed over time through periodic assessments or data collection. The data collected may include information on clinical outcomes, adverse events, changes in symptoms or functional status, and other relevant measures.

The results of follow-up studies can provide important insights into the long-term benefits and risks of medical interventions, as well as help to identify factors that may influence treatment effectiveness or patient outcomes. However, it is important to note that follow-up studies can be subject to various biases and limitations, such as loss to follow-up, recall bias, and changes in clinical practice over time, which must be carefully considered when interpreting the results.

Ocular toxoplasmosis is an inflammatory eye disease caused by the parasitic infection of Toxoplasma gondii in the eye's retina. It can lead to lesions and scarring in the retina, resulting in vision loss or impairment. The severity of ocular toxoplasmosis depends on the location and extent of the infection in the eye. In some cases, it may cause only mild symptoms, while in others, it can result in severe damage to the eye. Ocular toxoplasmosis is usually treated with medications that target the Toxoplasma gondii parasite, such as pyrimethamine and sulfadiazine, often combined with corticosteroids to reduce inflammation.

Pilocarpine is a cholinergic agonist, which means it stimulates the parasympathetic nervous system by binding to muscarinic receptors. It is primarily used in the treatment of dry mouth (xerostomia) caused by radiation therapy or Sjögren's syndrome, as well as in the management of glaucoma due to its ability to construct the pupils and reduce intraocular pressure. Pilocarpine can also be used to treat certain cardiovascular conditions and chronic bronchitis. It is available in various forms, including tablets, ophthalmic solutions, and topical gels.

Thiamylal is a fast-acting, ultra-short-acting barbiturate drug that is primarily used for the induction of anesthesia before surgical procedures. It works by depressing the central nervous system, producing sedation, relaxation, and hypnosis. Thiamylal has a rapid onset of action and its effects last only a short time, making it useful for quickly achieving a desired level of anesthesia while minimizing the risk of prolonged sedation or respiratory depression.

It is important to note that thiamylal should be administered under the close supervision of trained medical personnel, as its use carries certain risks and potential complications, such as cardiovascular and respiratory depression. Additionally, patients with a history of drug allergies, liver or kidney disease, or other medical conditions may require special precautions before receiving thiamylal.

Pregnancy-induced hypertension (PIH), also known as gestational hypertension, is a condition characterized by the new onset of high blood pressure (≥140 mm Hg systolic or ≥90 mm Hg diastolic) after 20 weeks of pregnancy in a woman who was normotensive before. It can sometimes progress to more severe conditions like preeclampsia and eclampsia, which are associated with damage to other organ systems such as the liver and kidneys.

PIH is typically classified into two types:

1. Gestational hypertension: This is when a woman develops high blood pressure after 20 weeks of pregnancy without any protein in the urine or evidence of damage to other organ systems. Women with gestational hypertension are at increased risk for preeclampsia and may require closer monitoring.

2. Preeclampsia: This is a more severe form of PIH, characterized by high blood pressure and proteinuria (≥0.3 g in a 24-hour urine collection) after 20 weeks of pregnancy. Preeclampsia can also involve damage to other organ systems, such as the liver, kidneys, or brain, and may progress to eclampsia, a life-threatening condition characterized by seizures.

The exact causes of PIH are not fully understood, but it is thought to be related to problems with the development and function of the blood vessels that supply the placenta. Risk factors for developing PIH include first-time pregnancies, obesity, older age, a history of chronic hypertension or kidney disease, and carrying multiples (twins, triplets, etc.).

Treatment for PIH depends on the severity of the condition and the gestational age of the pregnancy. In mild cases, close monitoring of blood pressure, urine protein levels, and fetal growth may be sufficient. More severe cases may require medication to lower blood pressure, corticosteroids to promote fetal lung maturity, or early delivery of the baby to prevent further complications.

Flicker Fusion is the frequency at which an intermittent light stimulus appears to be completely steady or continuous to the average human observer. In other words, it is the rate at which a flickering light source transitions from being perceived as distinct flashes to a smooth and constant emission of light. The exact threshold can vary depending on factors such as the intensity of the light, its size, and the observer's visual acuity.

Flicker Fusion has important implications in various fields, including visual perception research, display technology, and neurology. In clinical settings, assessing a patient's flicker fusion threshold can help diagnose or monitor conditions affecting the nervous system, such as multiple sclerosis or migraines.

A chronic disease is a long-term medical condition that often progresses slowly over a period of years and requires ongoing management and care. These diseases are typically not fully curable, but symptoms can be managed to improve quality of life. Common chronic diseases include heart disease, stroke, cancer, diabetes, arthritis, and COPD (chronic obstructive pulmonary disease). They are often associated with advanced age, although they can also affect children and younger adults. Chronic diseases can have significant impacts on individuals' physical, emotional, and social well-being, as well as on healthcare systems and society at large.

Evoked potentials, visual, also known as visually evoked potentials (VEPs), are electrical responses recorded from the brain following the presentation of a visual stimulus. These responses are typically measured using electroencephalography (EEG) and can provide information about the functioning of the visual pathways in the brain.

There are several types of VEPs, including pattern-reversal VEPs and flash VEPs. Pattern-reversal VEPs are elicited by presenting alternating checkerboard patterns, while flash VEPs are elicited by flashing a light. The responses are typically analyzed in terms of their latency (the time it takes for the response to occur) and amplitude (the size of the response).

VEPs are often used in clinical settings to help diagnose and monitor conditions that affect the visual system, such as multiple sclerosis, optic neuritis, and brainstem tumors. They can also be used in research to study the neural mechanisms underlying visual perception.

Glucocorticoids are a class of steroid hormones that are naturally produced in the adrenal gland, or can be synthetically manufactured. They play an essential role in the metabolism of carbohydrates, proteins, and fats, and have significant anti-inflammatory effects. Glucocorticoids suppress immune responses and inflammation by inhibiting the release of inflammatory mediators from various cells, such as mast cells, eosinophils, and lymphocytes. They are frequently used in medical treatment for a wide range of conditions, including allergies, asthma, rheumatoid arthritis, dermatological disorders, and certain cancers. Prolonged use or high doses of glucocorticoids can lead to several side effects, such as weight gain, mood changes, osteoporosis, and increased susceptibility to infections.

Carbonic anhydrase inhibitors are a class of medications that work by blocking the action of carbonic anhydrase, an enzyme that is responsible for converting carbon dioxide and water into carbonic acid. This enzyme is found in various tissues throughout the body, including the eyes, kidneys, and nervous system.

By inhibiting the activity of carbonic anhydrase, these medications can reduce the production of bicarbonate ions in the body, which helps to lower the rate of fluid buildup in certain tissues. As a result, carbonic anhydrase inhibitors are often used to treat conditions such as glaucoma, epilepsy, and altitude sickness.

In glaucoma, for example, these medications can help to reduce pressure within the eye by promoting the drainage of fluid from the eye. In epilepsy, carbonic anhydrase inhibitors can help to reduce the frequency and severity of seizures by reducing the acidity of the blood and brain. And in altitude sickness, these medications can help to alleviate symptoms such as headache, nausea, and shortness of breath by reducing the buildup of fluid in the lungs.

Some common examples of carbonic anhydrase inhibitors include acetazolamide, methazolamide, and dorzolamide. These medications are available in various forms, including tablets, capsules, and eye drops, and are typically prescribed by a healthcare professional.

The choroid is a layer of the eye that contains blood vessels that supply oxygen and nutrients to the outer layers of the retina. It lies between the sclera (the white, protective coat of the eye) and the retina (the light-sensitive tissue at the back of the eye). The choroid is essential for maintaining the health and function of the retina, particularly the photoreceptor cells that detect light and transmit visual signals to the brain. Damage to the choroid can lead to vision loss or impairment.

In the field of medicine, "time factors" refer to the duration of symptoms or time elapsed since the onset of a medical condition, which can have significant implications for diagnosis and treatment. Understanding time factors is crucial in determining the progression of a disease, evaluating the effectiveness of treatments, and making critical decisions regarding patient care.

For example, in stroke management, "time is brain," meaning that rapid intervention within a specific time frame (usually within 4.5 hours) is essential to administering tissue plasminogen activator (tPA), a clot-busting drug that can minimize brain damage and improve patient outcomes. Similarly, in trauma care, the "golden hour" concept emphasizes the importance of providing definitive care within the first 60 minutes after injury to increase survival rates and reduce morbidity.

Time factors also play a role in monitoring the progression of chronic conditions like diabetes or heart disease, where regular follow-ups and assessments help determine appropriate treatment adjustments and prevent complications. In infectious diseases, time factors are crucial for initiating antibiotic therapy and identifying potential outbreaks to control their spread.

Overall, "time factors" encompass the significance of recognizing and acting promptly in various medical scenarios to optimize patient outcomes and provide effective care.

Quinoxalines are not a medical term, but rather an organic chemical compound. They are a class of heterocyclic aromatic compounds made up of a benzene ring fused to a pyrazine ring. Quinoxalines have no specific medical relevance, but some of their derivatives have been synthesized and used in medicinal chemistry as antibacterial, antifungal, and antiviral agents. They are also used in the production of dyes and pigments.

A laser is not a medical term per se, but a physical concept that has important applications in medicine. The term "LASER" stands for "Light Amplification by Stimulated Emission of Radiation." It refers to a device that produces and amplifies light with specific characteristics, such as monochromaticity (single wavelength), coherence (all waves moving in the same direction), and high intensity.

In medicine, lasers are used for various therapeutic and diagnostic purposes, including surgery, dermatology, ophthalmology, and dentistry. They can be used to cut, coagulate, or vaporize tissues with great precision, minimizing damage to surrounding structures. Additionally, lasers can be used to detect and measure physiological parameters, such as blood flow and oxygen saturation.

It's important to note that while lasers are powerful tools in medicine, they must be used by trained professionals to ensure safe and effective treatment.

A pupil, in medical terms, refers to the circular opening in the center of the iris (the colored part of the eye) that allows light to enter and reach the retina. The size of the pupil can change involuntarily in response to light intensity and emotional state, as well as voluntarily through certain eye exercises or with the use of eye drops. Pupillary reactions are important in clinical examinations as they can provide valuable information about the nervous system's functioning, particularly the brainstem and cranial nerves II and III.

"Macaca fascicularis" is the scientific name for the crab-eating macaque, also known as the long-tailed macaque. It's a species of monkey that is native to Southeast Asia. They are called "crab-eating" macaques because they are known to eat crabs and other crustaceans. These monkeys are omnivorous and their diet also includes fruits, seeds, insects, and occasionally smaller vertebrates.

Crab-eating macaques are highly adaptable and can be found in a wide range of habitats, including forests, grasslands, and wetlands. They are also known to live in close proximity to human settlements and are often considered pests due to their tendency to raid crops and steal food from humans.

These monkeys are social animals and live in large groups called troops. They have a complex social structure with a clear hierarchy and dominant males. Crab-eating macaques are also known for their intelligence and problem-solving abilities.

In medical research, crab-eating macaques are often used as animal models due to their close genetic relationship to humans. They are used in studies related to infectious diseases, neuroscience, and reproductive biology, among others.

An amide is a functional group or a compound that contains a carbonyl group (a double-bonded carbon atom) and a nitrogen atom. The nitrogen atom is connected to the carbonyl carbon atom by a single bond, and it also has a lone pair of electrons. Amides are commonly found in proteins and peptides, where they form amide bonds (also known as peptide bonds) between individual amino acids.

The general structure of an amide is R-CO-NHR', where R and R' can be alkyl or aryl groups. Amides can be classified into several types based on the nature of R and R' substituents:

* Primary amides: R-CO-NH2
* Secondary amides: R-CO-NHR'
* Tertiary amides: R-CO-NR''R'''

Amides have several important chemical properties. They are generally stable and resistant to hydrolysis under neutral or basic conditions, but they can be hydrolyzed under acidic conditions or with strong bases. Amides also exhibit a characteristic infrared absorption band around 1650 cm-1 due to the carbonyl stretching vibration.

In addition to their prevalence in proteins and peptides, amides are also found in many natural and synthetic compounds, including pharmaceuticals, dyes, and polymers. They have a wide range of applications in chemistry, biology, and materials science.

Laser-Doppler flowmetry (LDF) is a non-invasive, investigative technique used to measure microcirculatory blood flow in real time. It is based on the principle of the Doppler effect, which describes the change in frequency or wavelength of light or sound waves as they encounter a moving object or reflect off a moving surface.

In LDF, a low-power laser beam is directed at the skin or other transparent tissue. The light penetrates the tissue and scatters off the moving red blood cells within the microvasculature. As the light scatters, it undergoes a slight frequency shift due to the movement of the red blood cells. This frequency shift is then detected by a photodetector, which converts it into an electrical signal. The magnitude of this signal is directly proportional to the speed and concentration of the moving red blood cells, providing a measure of microcirculatory blood flow.

LDF has various clinical applications, including the assessment of skin perfusion in patients with peripheral arterial disease, burn injuries, and flaps used in reconstructive surgery. It can also be used to study the effects of drugs or other interventions on microcirculation in research settings.

Retrospective studies, also known as retrospective research or looking back studies, are a type of observational study that examines data from the past to draw conclusions about possible causal relationships between risk factors and outcomes. In these studies, researchers analyze existing records, medical charts, or previously collected data to test a hypothesis or answer a specific research question.

Retrospective studies can be useful for generating hypotheses and identifying trends, but they have limitations compared to prospective studies, which follow participants forward in time from exposure to outcome. Retrospective studies are subject to biases such as recall bias, selection bias, and information bias, which can affect the validity of the results. Therefore, retrospective studies should be interpreted with caution and used primarily to generate hypotheses for further testing in prospective studies.

Triamcinolone Acetonide is a synthetic glucocorticoid, which is a class of corticosteroids. It is used in the form of topical creams, ointments, and sprays to reduce skin inflammation, itching, and allergies. It can also be administered through injection for the treatment of various conditions such as arthritis, bursitis, and tendonitis. Triamcinolone Acetonide works by suppressing the immune system's response, reducing inflammation, and blocking the production of substances that cause allergies.

It is important to note that prolonged use or overuse of triamcinolone acetonide can lead to side effects such as thinning of the skin, easy bruising, and increased susceptibility to infections. Therefore, it should be used under the guidance of a healthcare professional.

Sensory thresholds are the minimum levels of stimulation that are required to produce a sensation in an individual, as determined through psychophysical testing. These tests measure the point at which a person can just barely detect the presence of a stimulus, such as a sound, light, touch, or smell.

There are two types of sensory thresholds: absolute and difference. Absolute threshold is the minimum level of intensity required to detect a stimulus 50% of the time. Difference threshold, also known as just noticeable difference (JND), is the smallest change in intensity that can be detected between two stimuli.

Sensory thresholds can vary between individuals and are influenced by factors such as age, attention, motivation, and expectations. They are often used in clinical settings to assess sensory function and diagnose conditions such as hearing or vision loss.

Ophthalmology is a branch of medicine that deals with the diagnosis, treatment, and prevention of diseases and disorders of the eye and visual system. It is a surgical specialty, and ophthalmologists are medical doctors who complete additional years of training to become experts in eye care. They are qualified to perform eye exams, diagnose and treat eye diseases, prescribe glasses and contact lenses, and perform eye surgery. Some subspecialties within ophthalmology include cornea and external disease, glaucoma, neuro-ophthalmology, pediatric ophthalmology, retina and vitreous, and oculoplastics.

The double-blind method is a study design commonly used in research, including clinical trials, to minimize bias and ensure the objectivity of results. In this approach, both the participants and the researchers are unaware of which group the participants are assigned to, whether it be the experimental group or the control group. This means that neither the participants nor the researchers know who is receiving a particular treatment or placebo, thus reducing the potential for bias in the evaluation of outcomes. The assignment of participants to groups is typically done by a third party not involved in the study, and the codes are only revealed after all data have been collected and analyzed.

Sulfonamides are a group of synthetic antibacterial drugs that contain the sulfonamide group (SO2NH2) in their chemical structure. They are bacteriostatic agents, meaning they inhibit bacterial growth rather than killing them outright. Sulfonamides work by preventing the bacteria from synthesizing folic acid, which is essential for their survival.

The first sulfonamide drug was introduced in the 1930s and since then, many different sulfonamides have been developed with varying chemical structures and pharmacological properties. They are used to treat a wide range of bacterial infections, including urinary tract infections, respiratory tract infections, skin and soft tissue infections, and ear infections.

Some common sulfonamide drugs include sulfisoxazole, sulfamethoxazole, and trimethoprim-sulfamethoxazole (a combination of a sulfonamide and another antibiotic called trimethoprim). While sulfonamides are generally safe and effective when used as directed, they can cause side effects such as rash, nausea, and allergic reactions. It is important to follow the prescribing physician's instructions carefully and to report any unusual symptoms or side effects promptly.

Nerve fibers are specialized structures that constitute the long, slender processes (axons) of neurons (nerve cells). They are responsible for conducting electrical impulses, known as action potentials, away from the cell body and transmitting them to other neurons or effector organs such as muscles and glands. Nerve fibers are often surrounded by supportive cells called glial cells and are grouped together to form nerve bundles or nerves. These fibers can be myelinated (covered with a fatty insulating sheath called myelin) or unmyelinated, which influences the speed of impulse transmission.

The pulmonary artery is a large blood vessel that carries deoxygenated blood from the right ventricle of the heart to the lungs for oxygenation. It divides into two main branches, the right and left pulmonary arteries, which further divide into smaller vessels called arterioles, and then into a vast network of capillaries in the lungs where gas exchange occurs. The thin walls of these capillaries allow oxygen to diffuse into the blood and carbon dioxide to diffuse out, making the blood oxygen-rich before it is pumped back to the left side of the heart through the pulmonary veins. This process is crucial for maintaining proper oxygenation of the body's tissues and organs.

Treatment outcome is a term used to describe the result or effect of medical treatment on a patient's health status. It can be measured in various ways, such as through symptoms improvement, disease remission, reduced disability, improved quality of life, or survival rates. The treatment outcome helps healthcare providers evaluate the effectiveness of a particular treatment plan and make informed decisions about future care. It is also used in clinical research to compare the efficacy of different treatments and improve patient care.

Dexamethasone is a type of corticosteroid medication, which is a synthetic version of a natural hormone produced by the adrenal glands. It is often used to reduce inflammation and suppress the immune system in a variety of medical conditions, including allergies, asthma, rheumatoid arthritis, and certain skin conditions.

Dexamethasone works by binding to specific receptors in cells, which triggers a range of anti-inflammatory effects. These include reducing the production of chemicals that cause inflammation, suppressing the activity of immune cells, and stabilizing cell membranes.

In addition to its anti-inflammatory effects, dexamethasone can also be used to treat other medical conditions, such as certain types of cancer, brain swelling, and adrenal insufficiency. It is available in a variety of forms, including tablets, liquids, creams, and injectable solutions.

Like all medications, dexamethasone can have side effects, particularly if used for long periods of time or at high doses. These may include mood changes, increased appetite, weight gain, acne, thinning skin, easy bruising, and an increased risk of infections. It is important to follow the instructions of a healthcare provider when taking dexamethasone to minimize the risk of side effects.

Disease progression is the worsening or advancement of a medical condition over time. It refers to the natural course of a disease, including its development, the severity of symptoms and complications, and the impact on the patient's overall health and quality of life. Understanding disease progression is important for developing appropriate treatment plans, monitoring response to therapy, and predicting outcomes.

The rate of disease progression can vary widely depending on the type of medical condition, individual patient factors, and the effectiveness of treatment. Some diseases may progress rapidly over a short period of time, while others may progress more slowly over many years. In some cases, disease progression may be slowed or even halted with appropriate medical interventions, while in other cases, the progression may be inevitable and irreversible.

In clinical practice, healthcare providers closely monitor disease progression through regular assessments, imaging studies, and laboratory tests. This information is used to guide treatment decisions and adjust care plans as needed to optimize patient outcomes and improve quality of life.

SHR (Spontaneously Hypertensive Rats) are an inbred strain of rats that were originally developed through selective breeding for high blood pressure. They are widely used as a model to study hypertension and related cardiovascular diseases, as well as neurological disorders such as stroke and dementia.

Inbred strains of animals are created by mating genetically identical individuals (siblings or offspring) for many generations, resulting in a population that is highly homozygous at all genetic loci. This means that the animals within an inbred strain are essentially genetically identical to one another, which makes them useful for studying the effects of specific genes or environmental factors on disease processes.

SHR rats develop high blood pressure spontaneously, without any experimental manipulation, and show many features of human hypertension, such as increased vascular resistance, left ventricular hypertrophy, and renal dysfunction. They also exhibit a number of behavioral abnormalities, including hyperactivity, impulsivity, and cognitive deficits, which make them useful for studying the neurological consequences of hypertension and other cardiovascular diseases.

Overall, inbred SHR rats are an important tool in biomedical research, providing a valuable model for understanding the genetic and environmental factors that contribute to hypertension and related disorders.

Eye diseases are a range of conditions that affect the eye or visual system, causing damage to vision and, in some cases, leading to blindness. These diseases can be categorized into various types, including:

1. Refractive errors: These include myopia (nearsightedness), hyperopia (farsightedness), astigmatism, and presbyopia, which affect the way light is focused on the retina and can usually be corrected with glasses or contact lenses.
2. Cataracts: A clouding of the lens inside the eye that leads to blurry vision, glare, and decreased contrast sensitivity. Cataract surgery is the most common treatment for this condition.
3. Glaucoma: A group of diseases characterized by increased pressure in the eye, leading to damage to the optic nerve and potential blindness if left untreated. Treatment includes medications, laser therapy, or surgery.
4. Age-related macular degeneration (AMD): A progressive condition that affects the central part of the retina called the macula, causing blurry vision and, in advanced stages, loss of central vision. Treatment may include anti-VEGF injections, laser therapy, or nutritional supplements.
5. Diabetic retinopathy: A complication of diabetes that affects the blood vessels in the retina, leading to bleeding, leakage, and potential blindness if left untreated. Treatment includes laser therapy, anti-VEGF injections, or surgery.
6. Retinal detachment: A separation of the retina from its underlying tissue, which can lead to vision loss if not treated promptly with surgery.
7. Amblyopia (lazy eye): A condition where one eye does not develop normal vision, often due to a misalignment or refractive error in childhood. Treatment includes correcting the underlying problem and encouraging the use of the weaker eye through patching or other methods.
8. Strabismus (crossed eyes): A misalignment of the eyes that can lead to amblyopia if not treated promptly with surgery, glasses, or other methods.
9. Corneal diseases: Conditions that affect the transparent outer layer of the eye, such as keratoconus, Fuchs' dystrophy, and infectious keratitis, which can lead to vision loss if not treated promptly.
10. Uveitis: Inflammation of the middle layer of the eye, which can cause vision loss if not treated promptly with anti-inflammatory medications or surgery.

Ocular albinism is a type of albinism that primarily affects the eyes. It is a genetic disorder characterized by the reduction or absence of melanin, the pigment responsible for coloring the skin, hair, and eyes. In ocular albinism, melanin production is deficient in the eyes, leading to various eye abnormalities.

The main features of ocular albinism include:

1. Nystagmus: Rapid, involuntary back-and-forth movement of the eyes.
2. Iris transillumination: The iris appears translucent due to the lack of pigment, allowing light to pass through easily. This can be observed using a light source shone into the eye.
3. Foveal hypoplasia: Underdevelopment or absence of the fovea, a small pit in the retina responsible for sharp, central vision.
4. Photophobia: Increased sensitivity to light due to the lack of pigment in the eyes.
5. Strabismus: Misalignment of the eyes, which can result in double vision or lazy eye.
6. Reduced visual acuity: Decreased ability to see clearly, even with corrective lenses.

Ocular albinism is typically inherited as an X-linked recessive trait, meaning it primarily affects males, while females can be carriers of the condition. However, there are also autosomal recessive forms of ocular albinism that can affect both males and females equally. Treatment for ocular albinism usually involves managing symptoms with corrective lenses, low-vision aids, and vision therapy to improve visual skills.

Ocular dominance refers to the preference of one eye over the other in terms of visual perception and processing. In other words, it is the tendency for an individual to rely more heavily on the input from one particular eye when interpreting visual information. This can have implications in various visual tasks such as depth perception, aiming, and targeting.

Ocular dominance can be determined through a variety of tests, including the Miles test, the Porta test, or simply by observing which eye a person uses to align a visual target. It is important to note that ocular dominance does not necessarily indicate any sort of visual impairment or deficit; rather, it is a normal variation in the way that visual information is processed by the brain.

Renin is a medically recognized term and it is defined as:

"A protein (enzyme) that is produced and released by specialized cells (juxtaglomerular cells) in the kidney. Renin is a key component of the renin-angiotensin-aldosterone system (RAAS), which helps regulate blood pressure and fluid balance in the body.

When the kidney detects a decrease in blood pressure or a reduction in sodium levels, it releases renin into the bloodstream. Renin then acts on a protein called angiotensinogen, converting it to angiotensin I. Angiotensin-converting enzyme (ACE) subsequently converts angiotensin I to angiotensin II, which is a potent vasoconstrictor that narrows blood vessels and increases blood pressure.

Additionally, angiotensin II stimulates the adrenal glands to release aldosterone, a hormone that promotes sodium reabsorption in the kidneys and increases water retention, further raising blood pressure.

Therefore, renin plays a critical role in maintaining proper blood pressure and electrolyte balance in the body."

A cataract is a clouding of the natural lens in the eye that affects vision. This clouding can cause vision to become blurry, faded, or dim, making it difficult to see clearly. Cataracts are a common age-related condition, but they can also be caused by injury, disease, or medication use. In most cases, cataracts develop gradually over time and can be treated with surgery to remove the cloudy lens and replace it with an artificial one.

"Cell count" is a medical term that refers to the process of determining the number of cells present in a given volume or sample of fluid or tissue. This can be done through various laboratory methods, such as counting individual cells under a microscope using a specialized grid called a hemocytometer, or using automated cell counters that use light scattering and electrical impedance techniques to count and classify different types of cells.

Cell counts are used in a variety of medical contexts, including hematology (the study of blood and blood-forming tissues), microbiology (the study of microscopic organisms), and pathology (the study of diseases and their causes). For example, a complete blood count (CBC) is a routine laboratory test that includes a white blood cell (WBC) count, red blood cell (RBC) count, hemoglobin level, hematocrit value, and platelet count. Abnormal cell counts can indicate the presence of various medical conditions, such as infections, anemia, or leukemia.

Intracranial hypertension is a medical condition characterized by an increased pressure within the skull (intracranial space) that contains the brain, cerebrospinal fluid (CSF), and blood. Normally, the pressure inside the skull is carefully regulated to maintain a balance between the formation and absorption of CSF. However, when the production of CSF exceeds its absorption or when there is an obstruction in the flow of CSF, the pressure inside the skull can rise, leading to intracranial hypertension.

The symptoms of intracranial hypertension may include severe headaches, nausea, vomiting, visual disturbances such as blurred vision or double vision, and papilledema (swelling of the optic nerve disc). In some cases, intracranial hypertension can lead to serious complications such as vision loss, brain herniation, and even death if left untreated.

Intracranial hypertension can be idiopathic, meaning that there is no identifiable cause, or secondary to other underlying medical conditions such as brain tumors, meningitis, hydrocephalus, or certain medications. The diagnosis of intracranial hypertension typically involves a combination of clinical evaluation, imaging studies (such as MRI or CT scans), and lumbar puncture to measure the pressure inside the skull and assess the CSF composition. Treatment options may include medications to reduce CSF production, surgery to relieve pressure on the brain, or shunting procedures to drain excess CSF from the intracranial space.

Blood pressure determination is the medical procedure to measure and assess the force or pressure exerted by the blood on the walls of the arteries during a heartbeat cycle. It is typically measured in millimeters of mercury (mmHg) and is expressed as two numbers: systolic pressure (the higher number, representing the pressure when the heart beats and pushes blood out into the arteries) and diastolic pressure (the lower number, representing the pressure when the heart rests between beats). A normal blood pressure reading is typically around 120/80 mmHg. High blood pressure (hypertension) is defined as a consistently elevated blood pressure of 130/80 mmHg or higher, while low blood pressure (hypotension) is defined as a consistently low blood pressure below 90/60 mmHg. Blood pressure determination is an important vital sign and helps to evaluate overall cardiovascular health and identify potential health risks.

Ocular refraction is a medical term that refers to the bending of light as it passes through the optical media of the eye, including the cornea and lens. This process allows the eye to focus light onto the retina, creating a clear image. The refractive power of the eye is determined by the curvature and transparency of these structures.

In a normal eye, light rays are bent or refracted in such a way that they converge at a single point on the retina, producing a sharp and focused image. However, if the curvature of the cornea or lens is too steep or too flat, the light rays may not converge properly, resulting in a refractive error such as myopia (nearsightedness), hyperopia (farsightedness), or astigmatism.

Ocular refraction can be measured using a variety of techniques, including retinoscopy, automated refraction, and subjective refraction. These measurements are used to determine the appropriate prescription for corrective lenses such as eyeglasses or contact lenses. In some cases, ocular refractive errors may be corrected surgically through procedures such as LASIK or PRK.

Eye neoplasms, also known as ocular tumors or eye cancer, refer to abnormal growths of tissue in the eye. These growths can be benign (non-cancerous) or malignant (cancerous). Eye neoplasms can develop in various parts of the eye, including the eyelid, conjunctiva, cornea, iris, ciliary body, choroid, retina, and optic nerve.

Benign eye neoplasms are typically slow-growing and do not spread to other parts of the body. They may cause symptoms such as vision changes, eye pain, or a noticeable mass in the eye. Treatment options for benign eye neoplasms include monitoring, surgical removal, or radiation therapy.

Malignant eye neoplasms, on the other hand, can grow and spread rapidly to other parts of the body. They may cause symptoms such as vision changes, eye pain, floaters, or flashes of light. Treatment options for malignant eye neoplasms depend on the type and stage of cancer but may include surgery, radiation therapy, chemotherapy, or a combination of these treatments.

It is important to note that early detection and treatment of eye neoplasms can improve outcomes and prevent complications. Regular eye exams with an ophthalmologist are recommended for early detection and prevention of eye diseases, including eye neoplasms.

A kidney, in medical terms, is one of two bean-shaped organs located in the lower back region of the body. They are essential for maintaining homeostasis within the body by performing several crucial functions such as:

1. Regulation of water and electrolyte balance: Kidneys help regulate the amount of water and various electrolytes like sodium, potassium, and calcium in the bloodstream to maintain a stable internal environment.

2. Excretion of waste products: They filter waste products from the blood, including urea (a byproduct of protein metabolism), creatinine (a breakdown product of muscle tissue), and other harmful substances that result from normal cellular functions or external sources like medications and toxins.

3. Endocrine function: Kidneys produce several hormones with important roles in the body, such as erythropoietin (stimulates red blood cell production), renin (regulates blood pressure), and calcitriol (activated form of vitamin D that helps regulate calcium homeostasis).

4. pH balance regulation: Kidneys maintain the proper acid-base balance in the body by excreting either hydrogen ions or bicarbonate ions, depending on whether the blood is too acidic or too alkaline.

5. Blood pressure control: The kidneys play a significant role in regulating blood pressure through the renin-angiotensin-aldosterone system (RAAS), which constricts blood vessels and promotes sodium and water retention to increase blood volume and, consequently, blood pressure.

Anatomically, each kidney is approximately 10-12 cm long, 5-7 cm wide, and 3 cm thick, with a weight of about 120-170 grams. They are surrounded by a protective layer of fat and connected to the urinary system through the renal pelvis, ureters, bladder, and urethra.

WKY (Wistar Kyoto) is not a term that refers to "rats, inbred" in a medical definition. Instead, it is a strain of laboratory rat that is widely used in biomedical research. WKY rats are an inbred strain, which means they are the result of many generations of brother-sister matings, resulting in a genetically uniform population.

WKY rats originated from the Wistar Institute in Philadelphia and were established as a normotensive control strain to contrast with other rat strains that exhibit hypertension. They have since been used in various research areas, including cardiovascular, neurological, and behavioral studies. Compared to other commonly used rat strains like the spontaneously hypertensive rat (SHR), WKY rats are known for their lower blood pressure, reduced stress response, and greater emotionality.

In summary, "WKY" is a designation for an inbred strain of laboratory rat that is often used as a control group in biomedical research due to its normotensive characteristics.

Visual pattern recognition is the ability to identify and interpret patterns in visual information. In a medical context, it often refers to the process by which healthcare professionals recognize and diagnose medical conditions based on visible signs or symptoms. This can involve recognizing the characteristic appearance of a rash, wound, or other physical feature associated with a particular disease or condition. It may also involve recognizing patterns in medical images such as X-rays, CT scans, or MRIs.

In the field of radiology, for example, visual pattern recognition is a critical skill. Radiologists are trained to recognize the typical appearances of various diseases and conditions in medical images. This allows them to make accurate diagnoses based on the patterns they see. Similarly, dermatologists use visual pattern recognition to identify skin abnormalities and diseases based on the appearance of rashes, lesions, or other skin changes.

Overall, visual pattern recognition is an essential skill in many areas of medicine, allowing healthcare professionals to quickly and accurately diagnose medical conditions based on visible signs and symptoms.

Sprague-Dawley rats are a strain of albino laboratory rats that are widely used in scientific research. They were first developed by researchers H.H. Sprague and R.C. Dawley in the early 20th century, and have since become one of the most commonly used rat strains in biomedical research due to their relatively large size, ease of handling, and consistent genetic background.

Sprague-Dawley rats are outbred, which means that they are genetically diverse and do not suffer from the same limitations as inbred strains, which can have reduced fertility and increased susceptibility to certain diseases. They are also characterized by their docile nature and low levels of aggression, making them easier to handle and study than some other rat strains.

These rats are used in a wide variety of research areas, including toxicology, pharmacology, nutrition, cancer, and behavioral studies. Because they are genetically diverse, Sprague-Dawley rats can be used to model a range of human diseases and conditions, making them an important tool in the development of new drugs and therapies.

An axon is a long, slender extension of a neuron (a type of nerve cell) that conducts electrical impulses (nerve impulses) away from the cell body to target cells, such as other neurons or muscle cells. Axons can vary in length from a few micrometers to over a meter long and are typically surrounded by a myelin sheath, which helps to insulate and protect the axon and allows for faster transmission of nerve impulses.

Axons play a critical role in the functioning of the nervous system, as they provide the means by which neurons communicate with one another and with other cells in the body. Damage to axons can result in serious neurological problems, such as those seen in spinal cord injuries or neurodegenerative diseases like multiple sclerosis.

A cohort study is a type of observational study in which a group of individuals who share a common characteristic or exposure are followed up over time to determine the incidence of a specific outcome or outcomes. The cohort, or group, is defined based on the exposure status (e.g., exposed vs. unexposed) and then monitored prospectively to assess for the development of new health events or conditions.

Cohort studies can be either prospective or retrospective in design. In a prospective cohort study, participants are enrolled and followed forward in time from the beginning of the study. In contrast, in a retrospective cohort study, researchers identify a cohort that has already been assembled through medical records, insurance claims, or other sources and then look back in time to assess exposure status and health outcomes.

Cohort studies are useful for establishing causality between an exposure and an outcome because they allow researchers to observe the temporal relationship between the two. They can also provide information on the incidence of a disease or condition in different populations, which can be used to inform public health policy and interventions. However, cohort studies can be expensive and time-consuming to conduct, and they may be subject to bias if participants are not representative of the population or if there is loss to follow-up.

Prevalence, in medical terms, refers to the total number of people in a given population who have a particular disease or condition at a specific point in time, or over a specified period. It is typically expressed as a percentage or a ratio of the number of cases to the size of the population. Prevalence differs from incidence, which measures the number of new cases that develop during a certain period.

I believe there may be some confusion in your question. "Rabbits" is a common name used to refer to the Lagomorpha species, particularly members of the family Leporidae. They are small mammals known for their long ears, strong legs, and quick reproduction.

However, if you're referring to "rabbits" in a medical context, there is a term called "rabbit syndrome," which is a rare movement disorder characterized by repetitive, involuntary movements of the fingers, resembling those of a rabbit chewing. It is also known as "finger-chewing chorea." This condition is usually associated with certain medications, particularly antipsychotics, and typically resolves when the medication is stopped or adjusted.

Intraocular lens (IOL) implantation is a surgical procedure that involves placing a small artificial lens inside the eye to replace the natural lens that has been removed. This procedure is typically performed during cataract surgery, where the cloudy natural lens is removed and replaced with an IOL to restore clear vision.

During the procedure, a small incision is made in the eye, and the cloudy lens is broken up and removed using ultrasound waves or laser energy. Then, the folded IOL is inserted through the same incision and positioned in the correct place inside the eye. Once in place, the IOL unfolds and is secured into position.

There are several types of IOLs available, including monofocal, multifocal, toric, and accommodating lenses. Monofocal lenses provide clear vision at one distance, while multifocal lenses offer clear vision at multiple distances. Toric lenses correct astigmatism, and accommodating lenses can change shape to focus on objects at different distances.

Overall, intraocular lens implantation is a safe and effective procedure that can help restore clear vision in patients with cataracts or other eye conditions that require the removal of the natural lens.

Optical coherence tomography (OCT) is a non-invasive imaging technique that uses low-coherence light to capture high-resolution cross-sectional images of biological tissues, particularly the retina and other ocular structures. OCT works by measuring the echo time delay of light scattered back from different depths within the tissue, creating a detailed map of the tissue's structure. This technique is widely used in ophthalmology to diagnose and monitor various eye conditions such as macular degeneration, diabetic retinopathy, and glaucoma.

Desoxycorticosterone (also known as desoxycorticosterone or DCZ) is a natural steroid hormone produced by the adrenal gland. It is a weak glucocorticoid and mineralocorticoid, which means it has some effects on blood sugar metabolism and regulates electrolyte and fluid balance in the body.

Desoxycorticosterone is used as a medication in the form of its synthetic acetate ester, desoxycorticosterone acetate (DCA), to treat Addison's disease, a condition in which the adrenal glands do not produce enough steroid hormones. DCA helps to replace the missing mineralocorticoid activity and prevent the symptoms of low blood pressure, dehydration, and electrolyte imbalances associated with Addison's disease.

It is important to note that desoxycorticosterone should only be used under the supervision of a healthcare provider, as it can have significant side effects if not properly monitored.

Analysis of Variance (ANOVA) is a statistical technique used to compare the means of two or more groups and determine whether there are any significant differences between them. It is a way to analyze the variance in a dataset to determine whether the variability between groups is greater than the variability within groups, which can indicate that the groups are significantly different from one another.

ANOVA is based on the concept of partitioning the total variance in a dataset into two components: variance due to differences between group means (also known as "between-group variance") and variance due to differences within each group (also known as "within-group variance"). By comparing these two sources of variance, ANOVA can help researchers determine whether any observed differences between groups are statistically significant, or whether they could have occurred by chance.

ANOVA is a widely used technique in many areas of research, including biology, psychology, engineering, and business. It is often used to compare the means of two or more experimental groups, such as a treatment group and a control group, to determine whether the treatment had a significant effect. ANOVA can also be used to compare the means of different populations or subgroups within a population, to identify any differences that may exist between them.

Regional blood flow (RBF) refers to the rate at which blood flows through a specific region or organ in the body, typically expressed in milliliters per minute per 100 grams of tissue (ml/min/100g). It is an essential physiological parameter that reflects the delivery of oxygen and nutrients to tissues while removing waste products. RBF can be affected by various factors such as metabolic demands, neural regulation, hormonal influences, and changes in blood pressure or vascular resistance. Measuring RBF is crucial for understanding organ function, diagnosing diseases, and evaluating the effectiveness of treatments.

Ocular motility disorders refer to a group of conditions that affect the movement of the eyes. These disorders can result from nerve damage, muscle dysfunction, or brain injuries. They can cause abnormal eye alignment, limited range of motion, and difficulty coordinating eye movements. Common symptoms include double vision, blurry vision, strabismus (crossed eyes), nystagmus (involuntary eye movement), and difficulty tracking moving objects. Ocular motility disorders can be congenital or acquired and may require medical intervention to correct or manage the condition.

Rhodopsin, also known as visual purple, is a light-sensitive protein found in the rods of the eye's retina. It is a type of opsin, a class of proteins that are activated by light and play a crucial role in vision. Rhodopsin is composed of two parts: an apoprotein called opsin and a chromophore called 11-cis-retinal. When light hits the retina, it changes the shape of the 11-cis-retinal, which in turn activates the rhodopsin protein. This activation triggers a series of chemical reactions that ultimately lead to the transmission of a visual signal to the brain. Rhodopsin is highly sensitive to light and allows for vision in low-light conditions.

... is considered as ocular hypertension. Ocular hypertension is treated with either medications (eye drops), surgery, or laser. ... June 2002). "The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication ... Ocular hypertension is the presence of elevated fluid pressure inside the eye (intraocular pressure), usually with no optic ... It is estimated that approximately 2-3% of people aged 52-89 years old have ocular hypertension of 25 mmHg and higher, and 3.5 ...
As an eye drop it is used to manage angle closure glaucoma until surgery can be performed, ocular hypertension, primary open ... "Glaucoma and ocular hypertension. NICE guideline 81". National Institute for Health and Care Excellence. November 2017. ... Ocular hypertension... alternative options include carbonic anhydrase inhibitors such as brinzolamide or dorzolamide, a topical ... Bartlett JD, James SD (October 2013). "Drug Affect the Autonomous Nervous System". Clinical Ocular Pharmacology. Elsevier. p. ...
Treatment of Ocular Hypertension". ayurajan. Retrieved 2016-11-21. "新薬の承認に関する情報". www.pmda.go.jp. Retrieved 2016-11-21. " ... over 24 hours in primary open-angle glaucoma and ocular hypertension: a randomized, open-label, crossover study". Acta ... used for the treatment of glaucoma and ocular hypertension. Ripasudil's mechanism of action affects intraocular pressure, or ... in combination with timolol or latanoprost in primary open-angle glaucoma and ocular hypertension". World Ophthalmology ...
Ocular Hypertension, American Optometric Association. Accessed 2015-11-3. "Ocular Hypotony: Background, Pathophysiology, ... Ocular hypertension (OHT) is defined by intraocular pressure being higher than normal, in the absence of optic nerve damage or ... Ocular hypertension is the most important risk factor for glaucoma. Intraocular pressure has been measured as an outcome in a ... www.allaboutvision.com What To Expect During a Comprehensive Eye Exam www.emedicinehealth.com Ocular Hypertension www. ...
Labeled with older label of 'sinus venosus scleræ' at center top.) Intraocular pressure Ocular hypertension Aspelund, ... "A lymphatic defect causes ocular hypertension and glaucoma in mice". The Journal of Clinical Investigation. 124 (10): 4320-24. ...
Open angle glaucoma, ocular hypertension, low-tension glaucoma, and refraction. Arch Ophthalmol 1982;100(9):1464-7. Blondeau P ... The "no treatment" approach to ocular hypertension. Surv Ophthalmol 1980;25(3):175-82. Phelps CD, Armaly MF. Measurement of ... Ocular hypotony after retinal vascular occlusion. Trans Ophthalmol Soc U K 1977;97(4):756-67. Perez RN, Phelps CD, Burton TC. ...
Ocular hypertension is often wrongly considered a cause, but actually it is a risk factor. Ocular hypertension (increased ... of people with primary open-angle glaucoma actually have elevated ocular pressure. Ocular hypertension-an intraocular pressure ... Postoperative ocular hypertension from use of alpha chymotrypsin. Glaucoma of miscellaneous origin Associated with intraocular ... Kelly SR, Khawaja AP, Bryan SR, Azuara-Blanco A, Sparrow JM, Crabb DP (October 2020). "Progression from ocular hypertension to ...
Ocular hypertension Karpinich NO, Caron KM (September 2014). "Schlemm's canal: more than meets the eye, lymphatics in disguise ... Sampaolesi R, Sampaolesi JR, Zárate J (2009). "Ocular Embryology with Special Reference to Chamber Angle Development". The ...
This includes ocular hypertension and open angle glaucoma. It is applied as eye drops to the eyes. Onset of effects is usually ... In the United States, latanoprost is indicated for patients with open-angle glaucoma or ocular hypertension to reduce ... An Update of its Use in Glaucoma and Ocular Hypertension". Drugs & Aging. 20 (8): 597-630. doi:10.2165/00002512-200320080-00005 ... In people with ocular hypertension (IOP ≥21 mm Hg) including open-angle glaucoma, treatment with latanoprost reduced IOP levels ...
Croxtall JD, Scott LJ (2009). "Brinzolamide/timolol: in open-angle glaucoma and ocular hypertension". Drugs & Aging. 26 (5): ... in patients with primary open-angle glaucoma or ocular hypertension". Am J Ophthalmol. 129 (2): 136-143. doi:10.1016/S0002-9394 ... Following ocular instillation, the suspension is systemically absorbed to some degree; however the plasma concentrations are ... Kaup M, Plange N, Niegel M, Remky A, Arend O (2004). "Effects of brinzolamide on ocular haemodynamics in healthy volunteers". ...
"Current management of uveitis-associated ocular hypertension and glaucoma". Survey of Ophthalmology. 65 (4): 397-407. doi: ... Cataract is an ocular disease, identified by the progressive clouding of the lens. Surgical procedures are often employed to ... Glaucoma associated with ocular tumours: Although each tumour subtype has its own mechanism in causing secondary glaucoma, the ... There is an increased risk of development of posterior synechiae in glaucoma secondary to exfoliation syndrome and ocular ...
"Medical interventions for primary open angle glaucoma and ocular hypertension". The Cochrane Database of Systematic Reviews. ... Nitric oxide donators Rho kinase inhibitors When comparing people with primary open-angle glaucoma and ocular hypertension, ...
... is indicated for the treatment of glaucoma and ocular hypertension. The most common adverse effects of omidenepag ... is a medication used for the treatment of glaucoma and ocular hypertension. Omidenepag was approved for medical use in Japan in ... for the Reduction of Elevated Intraocular Pressure in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension" (Press ... January 2018). "Pharmacologic Characterization of Omidenepag Isopropyl, a Novel Selective EP2 Receptor Agonist, as an Ocular ...
"Ocular hypotensive effect of the Rho kinase inhibitor AR-12286 in patients with glaucoma and ocular hypertension". American ... Ripasudil, used in Japan for the treatment of glaucoma and ocular hypertension. TCS-7001 Thiazovivin Verosudil (AR-12286) Y- ... approved in United States for glaucoma and ocular hypertension. RKI-1447, a potent small molecule inhibitor of ROCK1 and ROCK2 ...
... is used for the treatment of open-angle glaucoma and ocular hypertension in adults, either alone or in combination ... Curran MP (2009). "Bimatoprost: a review of its use in open-angle glaucoma and ocular hypertension". Drugs & Aging. 26 (12): ...
Ocular signs of arterial hypertension include mydriasis, hyphema, or blindness due to retinal detachment and/or intraocular ... Most affected cats present with muscular weakness and/or ocular signs of hypertension. Signs of muscle weakness can include a ... Increased sodium and water retention results in systemic arterial hypertension. This increase in active sodium reabsorption ...
A 13-oxaprostaglandin analogue has been shown to treat glaucoma and ocular hypertension. The 11-oxa prostaglandin analogue AL- ... 12182 1 has potent topical ocular hypotensive activity. 7-Oxa-13-prostynoic acid promotes erythrocyte lysis and dissolution of ...
"Latrunculin B Reduces Intraocular Pressure in Human Ocular Hypertension and Primary Open-Angle Glaucoma". Translational Vision ...
Retinal detachment, Ocular hypertension and IOL dislocation are the major complications of posterior capsulotomy.[clarification ...
In 2002, the five-year report of the Ocular Hypertension Study (OHTS) was released. The study reported that corneal thickness ... 1] Eisner, R; Israel, R (November 1, 2006). "Corneal waveform measurements has advantages in pachymetry". Ocular Surgery News. ...
Kwon, YH (4 March 2016). "The Utility of Diaton Tonometer Measurements in Patients With Ocular Hypertension, Glaucoma, and ... including those with ocular hypertension, glaucoma, and glaucoma tube shunts). Non-contact tonometry (or air-puff tonometry) is ... The Ocular Response Analyzer and Pascal DCT Tonometers are less affected by CCT than the Goldmann tonometer. Conversely, non- ... Robert N. Weinreb, James D. Brandt, David Garway-Heath and Felipe A. Medeiros 2007 "4th Consensus Meeting:Intra-Ocular Pressure ...
Hoy SM (May 2018). "Latanoprostene Bunod Ophthalmic Solution 0.024%: A Review in Open-Angle Glaucoma and Ocular Hypertension". ... "FDA Approves Vyzulta (latanoprostene bunod) Ophthalmic Solution for Open-Angle Glaucoma, Ocular Hypertension" (Press release). ... the United States in 2017 for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension ...
A review of its pharmacological properties, and therapeutic efficacy in glaucoma and ocular hypertension". Drugs. 40 (1): 75-90 ... Betaxolol is a selective beta1 receptor blocker used in the treatment of hypertension and angina. Being selective for beta1 ... Betaxolol is most commonly ingested orally alone or with other medications for the management of essential hypertension. It is ... Ophthalmic betaxolol is an available treatment for primary open angle glaucoma (POAG) and optical hypertension. Betaxolol ...
Her mother had lost her sight at the age of 15 due to ocular hypertension. Despite her visual impairment, she finished her ...
... was found to be expressed in the normal retina and was up regulated in RCGs after the induction of ocular hypertension ... It has been shown that the first symptoms of this disease are usually ocular hypertension. Elevated IOP (intraocular pressure) ... the combined treatment of both provides long term RCG neuroprotection after the induction of ocular hypertension. In conclusion ... binds to BDNF receptor and TrkB inhibiting the activation of TkrB by binding of BNDF after the induction of ocular hypertension ...
... is an α2 agonist medication used to treat open-angle glaucoma, ocular hypertension, and rosacea. In rosacea it ... Brimonidine is indicated for the lowering of intraocular pressure in patients with open-angle glaucoma or ocular hypertension. ... "Acute versus chronic effects of brimonidine on aqueous humor dynamics in ocular hypertensive patients". American Journal of ...
... hydrochloride is used to lower excessive intraocular pressure in open-angle glaucoma and ocular hypertension. This ... Ocular stinging, burning, itching and bitter taste. It causes shallowing of the anterior chamber and leads to transient myopia ...
... a review of its pharmacology and use in the treatment of chronic open-angle glaucoma and ocular hypertension". Clinical ... It is indicated for intraocular pressure reduction in patients with open-angle glaucoma or ocular hypertension. Levobetaxolol ... When applied topically, it reduces intra-ocular pressure (IOP) by 16-23% depending on time of day and the individual. It also ... The drug has been associated with bradycardia and hypertension.[citation needed] Levobetaxolol was developed in the 1980s. It ...
Long-term follow-up of diode laser tabeculoplasty for open-angle glaucoma and ocular hypertension. Ophthalmology 100:11; 1614- ... He has published extensively in the field of ophthalmology, on a broad range of ocular problems. This has included age-related ...
Cunningham, Emmett T.; Zierhut, Manfred (2017-11-02). "Uveitic Ocular Hypertension and Glaucoma". Ocular Immunology and ... Corticosteroid-induced ocular hypertension typically develops 2 to 6 weeks after starting therapy but can occur at any time ... While the pathogenesis of corticosteroid-induced ocular hypertension is not fully understood, it likely involves swelling and ... Flare is the leakage of various proteins (such as fibrin and cytokines) into the ocular anterior chamber, as a manifestation of ...
Ocular Hypertension Treatment Study: This study measured the effectiveness of medicated eye drops to treat high eye pressure to ... "The Ocular Hypertension Treatment Study". jamanetwork.com. Retrieved 2023-03-21. "Amblyopia in Children Aged 7 to 17 Years". ...
In some cases, abnormally high pressure inside the eyeball (ocular hypertension) can also result. Despite the name, the eye ...
... is considered as ocular hypertension. Ocular hypertension is treated with either medications (eye drops), surgery, or laser. ... June 2002). "The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication ... Ocular hypertension is the presence of elevated fluid pressure inside the eye (intraocular pressure), usually with no optic ... It is estimated that approximately 2-3% of people aged 52-89 years old have ocular hypertension of 25 mmHg and higher, and 3.5 ...
Ocular hypertension (OHT) can be used as a generic term referring to any situation in which intraocular pressure (IOP) is ... The Ocular Hypertension Treatment Study (OHTS) states that over a 5-year-period, patients with ocular hypertension and IOP ... Management of ocular hypertension: a cost-effectiveness approach from the Ocular Hypertension Treatment Study. Am J Ophthalmol ... encoded search term (Ocular Hypertension) and Ocular Hypertension What to Read Next on Medscape ...
Wungrak Choi describes the outcomes from his recent study that evaluated the risk of steroid-induced ocular hypertension (OHT) ... Risk Factors for Steroid-Induced Ocular Hypertension After Intravitreal DEX Implantation By Eric L Crowell, MD, Wungrak Choi, ... Wungrak Choi describes the outcomes from his recent study that evaluated the risk of steroid-induced ocular hypertension (OHT) ... hypertension, depression, diabetes mellitus, and a history of prior LASEK or LASIK. Dr. Choi and colleagues subsequently ...
... and a variety of ocular disorders that were previously considered to be primarily manifestations of arterial hypertension. ... There are well-known associations between systemic arterial hypertension ... Role of nocturnal arterial hypotension in the development of ocular manifestations of systemic arterial hypertension Curr Opin ... There are well-known associations between systemic arterial hypertension and a variety of ocular disorders that were previously ...
... and disease severity in newly diagnosed ocular hypertension (OH) or open-angle glaucoma (OAG). ,i ,Methods,/i,. Eligible ... i ,Purpose,/i,. To describe the distribution of ocular variables, risk factors, ... To describe the distribution of ocular variables, risk factors, and disease severity in newly diagnosed ocular hypertension (OH ... E. S. Perkins and C. D. Phelps, "Open angle glaucoma, ocular hypertension, low-tension glaucoma, and refraction," Archives of ...
We tested linkage of OAG and ocular hypertension (OHT), a major risk factor for OAG, to GLC1A in eight French famil … ... We tested linkage of OAG and ocular hypertension (OHT), a major risk factor for OAG, to GLC1A in eight French families with ... Genetic heterogeneity of primary open angle glaucoma and ocular hypertension: linkage to GLC1A associated with an increased ...
Ocular Hyper Tension and Glaucoma. .fusion-breadcrumbs.fusion-breadcrumbs-1{font-size:13px;}.fusion-breadcrumbs.fusion- ...
The ocular hypertension treatment study: a raondmized trial determines that topical hypotensive medication dealys or prevents ... Risk assessment in the management of patients with ocular hypertension. Am J Ophthalmol 2004;138:458-67. ... Ocular TEAEs in treated fellow eyes were similar to those in study eyes. All ocular TEAEs were mild or moderate in severity. ... Latanoprost 0.005% test formulation is as effective as Xalatan® in patients with ocular hypertension and primary open-angle ...
Bilateral keratoconus with ocular hypertension and the natural cure of one eye. KK Bisaria Department of Ophthalmology, King ... Bisaria K K. Bilateral keratoconus with ocular hypertension and the natural cure of one eye.Indian J Ophthalmol 1967;15:197-199 ... Bisaria K K. Bilateral keratoconus with ocular hypertension and the natural cure of one eye. Indian J Ophthalmol [serial online ... Ocular Examination. -(After two months). She came this time with marked pain, lacrimation and photo�phobia in the left eye for ...
Chronic Ocular Hypertension Induced by Circumlimbal Suture in Rats Hsin-Hua Liu; Bang V. Bui; Christine T. O. Nguyen; Jelena M ... Hsin-Hua Liu, Bang V. Bui, Christine T. O. Nguyen, Jelena M. Kezic, Algis J. Vingrys, Zheng He; Chronic Ocular Hypertension ... OHT, ocular hypertension; ControlO, untreated fellow control eye for the OHT group; ControlS, untreated fellow control eye for ... OHT, ocular hypertension; ControlO, untreated fellow control eye for the OHT group; ControlS, untreated fellow control eye for ...
Keywords: Glaucoma progression; Ocular hypertension; Open-angle glaucoma; Selective laser trabeculoplasty Clinical Paper of the ... PURPOSE: The Laser in Glaucoma and Ocular Hypertension (LiGHT) Trial has shown selective laser trabeculoplasty (SLT) to be ... Laser in Glaucoma and Ocular Hypertension (LiGHT) Trial: Six-Year Results of Primary Selective Laser Trabeculoplasty versus Eye ... and ocular hypertension (OHT) at 3 years. This article reports health-related quality of life (HRQoL) and clinical ...
... and causes of systemic hypertension in cats with hypertensive retinopathy. DESIGN: Retrospective study. ANIMALS: 69 cats with ... are common in cats with hypertension. Primary hypertension in cats may be more common than currently recognized. Hypertension ... Cats with hypertension-induced ocular disease should be evaluated for renal failure, hyperthyroidism, diabetes mellitus, and ... Ocular Lesions Associated with Systemic Hypertension in Cats: 69 Cases (1985-1998). ...
Postoperative ocular hypertension (POH) describes the elevation of pressures within the eye during the acute postoperative ... reduces the prevalence and/or severity of postoperative ocular hypertension (POH) in dogs undergoing cataract extraction by ... Development of cataracts is a relatively frequent ocular disease of the dog and cataract extraction via phacoemulsification (PE ... Postoperative ocular hypertension (POH) describes the elevation of pressures within the eye during the acute postoperative ...
What are the signs and causes of Ocular Hypertension? Can it be treated by my eye doctor during an eye exam? Click here for ...
What are the signs and causes of Ocular Hypertension? Can it be treated by my eye doctor during an eye exam? Click here for ...
What are the signs and causes of Ocular Hypertension? Can it be treated by my eye doctor during an eye exam? Click here for ...
Ocular hypertension is a condition in which the pressure in the eye is elevated above a healthy level. Patients with this ... Alone, ocular hypertension will not result in pain or diminished sight.. Because ocular hypertension creates no outward signs ... Ocular hypertension is a condition in which the pressure in the eye is elevated above a healthy level. Patients with this ...
"Ocular Hypertension" by people in this website by year, and whether "Ocular Hypertension" was a major or minor topic of these ... "Ocular Hypertension" is a descriptor in the National Library of Medicines controlled vocabulary thesaurus, MeSH (Medical ... Below are the most recent publications written about "Ocular Hypertension" by people in Profiles. ... Below are MeSH descriptors whose meaning is more general than "Ocular Hypertension". ...
Steroid-induced ocular hypertension and effects of glucocorticoids on the trabecular meshwork. ... Dive into the research topics of Steroid-induced ocular hypertension and effects of glucocorticoids on the trabecular meshwork ...
Ocular_Hypertension,,span class=tocnumber,1,/span, ,span class=toctext,Ocular Hypertension,/span,,/a,,/li, ,li class= ... You may have whats known as ocular hypertension. Will you be treated? If you have ocular hypertension you may be wondering if ... Enter the Ocular Hypertension Treatment Study (OHTS). In 2002 the results of the long-awaited Ocular Hypertension Treatment ... Ocular Hypertension As you read in the The Basics of Glaucoma article if we were to randomly sample the eye pressures of 1000 ...
Ocular hypertension can often occur after an open-globe injury. What should physicians look out for in these patients, and how ... Ocular Hypertension After Open-globe Injury. by Medscape • 2014/01/27. • 0 Comments ...
Dorzolamide Eye Drops are used to treat open angle glaucoma and ocular hypertension. BUY the eye drops from Cheap Medicine Shop ...
A new study in the Journal of Clinical Medicine reveals ocular hypertension can have a protective effect against glaucoma, a ... Why do patients with ocular hypertension not have the optic nerve damage that is glaucoma? After all, ocular hypertension is ... New Study Reveals Ocular Hypertension Can Prevent Glaucoma. A new study in the Journal of Clinical Medicine reveals ocular ... Ocular Hypertension. For patients with glaucoma, elevated intraocular pressure is quite dangerous. However, according to a new ...
Al Owaifeer AM, Al-Omair S, Alrefaie S, Alenezi SH, Al-Shahwan S. Incidence and risk factors of ocular hypertension and ... Ocular hypertension (OHT) and glaucoma are frequent complications in Acanthamoeba keratitis (AK), according to findings ... Close more info about Ocular Hypertension, Glaucoma Frequent Complications of Acanthamoeba Keratitis ... Close more info about Ocular Hypertension, Glaucoma Frequent Complications of Acanthamoeba Keratitis ...
Sylentis will start the phase I study of its glaucoma-associated ocular hypertension drug SYL040012 in Spain around the end of ... Sylentis to Start Clinical Trial of SYL040012 for the Treatment of Ocular Hypertension. August 27, 2009 ... that the organization expects to dose the first patients in the phase I study of its glaucoma-associated ocular hypertension ...
Not all people with ocular hypertension will develop glaucoma. However, people with this condition have an increased risk of ... How is Ocular Hypertension Diagnosed?. An eye examination is a primary method to diagnose ocular hypertension. Since condition ... Treatment for Ocular Hypertension. Ocular hypertension is treated with prescription eye drops that can help aqueous humor drain ... Home » Disease • health and medicine » Does Ocular Hypertension Always Cause Glaucoma?. Does Ocular Hypertension Always Cause ...
Around half of ocular melanomas are class 1, which carry a low risk of metastasis. The other half are class 2, which have a ... The ocular tissue where these tumors arise, the uvea, is a densely pigmented layer that lies for the most part between the ... The incidence of ocular melanoma among Blacks is extremely rare. Hispanics and Asians are thought to have an intermediate risk ... 4. The Collaborative Ocular Melanoma Study Group. Arch Ophthalmol. 1997 Jul. 115(7):886-93. [QxMD MEDLINE Link]. ...
keywords = "cornea, intraocular pressure, glaucoma, glaucoma open angle, ocular hypertension, ocular tonometry", ... in ocular hypertension (OHT), primary open-angle (POAG) and normal tension glaucoma (NTG) eyes using multiple tonometry devices ... in ocular hypertension (OHT), primary open-angle (POAG) and normal tension glaucoma (NTG) eyes using multiple tonometry devices ... in ocular hypertension (OHT), primary open-angle (POAG) and normal tension glaucoma (NTG) eyes using multiple tonometry devices ...
Steroid-Induced Ocular Hypertension in Normal Cattle. Rosana Gerometta, MD; Steven M. Podos, MD; Oscar A. Candia, MD; et al ... Clark AF Steroids, ocular hypertension and glaucoma. J Glaucoma. 1995;4354- 369Google Scholar ... Zhan GMiranda OCBito LZ Steroid glaucoma: corticosteroid-induced ocular hypertension in cats. Exp Eye Res. 1992;54211- 218 ... Corticosteroids will induce ocular hypertension in rabbits,but the results are quite variable, and the amount of corticosteroid ...
  • Currently, the literature presents conflicting evidence regarding the effect of flavonoids on patients with glaucoma and ocular hypertension. (sightsavers.org)
  • Tafluprost controls glaucoma and ocular hypertension but does not cure them. (medlineplus.gov)
  • HLA antigens in glaucoma and ocular hypertension. (bmj.com)
  • One study found that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. (wikipedia.org)
  • With the development of potent arterial hypotensive medications for arterial hypertension, arterial hypotension (particularly nocturnal hypotension) is increasingly emerging as an important cause of visual disorders. (nih.gov)
  • Therefore, it is strongly recommended that when a patient is at risk for ocular or optic nerve head ischemic or ocular vascular disorders, the ophthalmologist should talk to the treating physician about the potential risks of intensive arterial hypotensive therapy, particularly that administered in the evening or at bedtime. (nih.gov)
  • Exclusion criteria included subjects previously or currently receiving ocular hypotensive therapy, a history of ocular surgery (except cataract surgery), or ocular trauma. (hindawi.com)
  • In the first phase, participants were given topical ocular hypotensive medication or close observation for ocular hypotensive disorder. (optometrytimes.com)
  • To evaluate the ocular hypotensive efficacy of 0.05%, 0.1% and 0.25% AR-12286 Ophthalmic Solutions in patients diagnosed with ocular hypertension or glaucoma. (entokey.com)
  • AR-12286 was well tolerated and provided clinically and statistically significant ocular hypotensive efficacy in patients with ocular hypertension and glaucoma. (entokey.com)
  • The objectives of this study were to evaluate the ocular hypotensive efficacy along with the ocular and systemic safety of AR-12286 ophthalmic solutions. (entokey.com)
  • Ocular hypertension is the presence of elevated fluid pressure inside the eye (intraocular pressure), usually with no optic nerve damage or visual field loss. (wikipedia.org)
  • Ocular hypertension (OHT) can be used as a generic term referring to any situation in which intraocular pressure (IOP) is greater than 21 mm Hg, the widely accepted upper limit of normal intraocular pressure in the general population. (medscape.com)
  • The exact pathophysiology of elevated intraocular pressure (IOP) in ocular hypertension is not known. (medscape.com)
  • Presently, risk factors with strongest evidence for conversion of ocular hypertension (OH) to glaucoma, or presence and progression of open-angle glaucoma (OAG), include older age, thinner central corneal thickness (CCT), greater cup-to-disc ratio (C/D ratio), and higher intraocular pressure (IOP). (hindawi.com)
  • After all, ocular hypertension is when intraocular pressure is higher than "normal. (associatedeyewichita.com)
  • During the exam, your eye doctor can test your intraocular pressure and determine whether you have ocular hypertension or are at risk for glaucoma. (associatedeyewichita.com)
  • Purpose: To analyse the relationship between measured intraocular pressure (IOP) and central corneal thickness (CCT), corneal hysteresis (CH) and corneal resistance factor (CRF) in ocular hypertension (OHT), primary open-angle (POAG) and normal tension glaucoma (NTG) eyes using multiple tonometry devices. (aston.ac.uk)
  • After surgery, 70 eyes (47.9%) had at least 1 period of ocular hypertension, with a mean intraocular pressure (IOP) of 27.15+/-5.66 mm Hg. (glaucoma.org.il)
  • Studies have, however, focused on the ocular surface, with limited research on the impact of PM 2.5 on intraocular pressure (IOP). (biomedcentral.com)
  • This study provides novel evidence that PM 2.5 has a direct toxic effect on intraocular tissues and may contribute to the initiation and development of ocular hypertension and glaucoma. (biomedcentral.com)
  • However, these PM-associated studies focused on the ocular surface, with little consideration of the particles' potential to penetrate the human cornea and affect tissues within the eye, and their involvement in the initiation and development of the intraocular diseases. (biomedcentral.com)
  • The current findings suggest that, apart from its involvement in ocular surface disease, PM 2.5 pollution also affects tissues inside the eye, possibly participating in the development of intraocular diseases such as glaucoma. (biomedcentral.com)
  • Although glaucoma treatments alter aqueous humor (AH) dynamics to lower intraocular pressure, the regulatory mechanisms of AH circulation and their contributions to the pathogenesis of ocular hypertension and glaucoma remain unclear. (nyu.edu)
  • The FDA has approved a New Drug Application for Vyzulta for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension. (europeanpharmaceuticalreview.com)
  • In this interview from AAO 2021, Dr. Wungrak Choi describes the outcomes from his recent study that evaluated the risk of steroid-induced ocular hypertension (OHT) after intravitreal dexamethasone (DEX) implantation. (aao.org)
  • We previously demonstrated that GTE is a potent anti-inflammatory and anti-oxidative agent in the eye, alleviating the endotoxin-induced acute anterior uveitis and sodium iodate-induced retinal degeneration in rats 13 , 14 , suggesting a potential treatment for ocular diseases. (nature.com)
  • The Ocular Hypertension Treatment Study (OHTS) is a multicenter, prospective, randomized, controlled clinical trial studying more than 1800 research subjects, evaluating the safety and efficacy of medical treatment in preventing or delaying the onset of visual-field loss and/or optic nerve damage in patients with ocular hypertension who are at moderate risk for developing primary open-angle glaucoma (POAG). (medscape.com)
  • However, according to a new study from LSU Health New Orleans Neuroscience Center of Excellence and the University of Copenhagen, some glaucoma patients do not have this same sensitivity: those with ocular hypertension. (associatedeyewichita.com)
  • Why do patients with ocular hypertension not have the optic nerve damage that is glaucoma? (associatedeyewichita.com)
  • The study suggests patients with ocular hypertension possess "increased antioxidant capacity and higher levels of anti-inflammatory, omega-3-derived chemical messengers involved in sustaining cell function in their plasma compared to patients with normal-tension glaucoma and age-matched controls. (associatedeyewichita.com)
  • Sylentis has announced that the organization expects to dose the first patients in the phase I study of its glaucoma-associated ocular hypertension drug SYL040012 in Spain around the end of September. (eyedocnews.com)
  • The fact that only about 25% of the patients in this cohort progressed on visual field studies will aid in shedding light on those ocular hypertensives who do not require IOP-lowering therapy. (optometrytimes.com)
  • The incidence of ocular hypertension after PKP is high, and at least 1 episode of high IOP was noted in almost half of our patients. (glaucoma.org.il)
  • PURPOSE: To assess the therapeutic noninferiority of 0.005% latanoprost ophthalmic solution versus Xalatan in the treatment of patients with primary open-angle glaucoma or ocular hypertension. (unimi.it)
  • A total of 184 patients with a diagnosis of unilateral or bilateral primary open-angle glaucoma or ocular hypertension were randomly assigned to either 0.005% latanoprost ophthalmic solution or Xalatan for 12 weeks. (unimi.it)
  • An evaluation of therapeutic noninferiority of 0.005% latanoprost ophthalmic solution and xalatan in patients with glaucoma or ocular hypertension / M. Digiuni, G. Manni, M. Vetrugno, M. Uva, G. Milano, N. Orzalesi, P. Fogagnolo, M. Centofanti, E. Campos, L. Rossetti. (unimi.it)
  • Studies such as the Early Manifest Glaucoma Trial, the Ocular Hypertension Treatment Study, and the Collaborative Normal Tension Glaucoma Study support the role of lowering IOP in reducing the risk of glaucomatous progression in patients with ocular hypertension and glaucoma. (entokey.com)
  • Purpose: To compare the ocular surface tolerability of latanoprost 0.005% preserved with 0.02% benzalkonium chloride (BAK), bimatoprost 0.03% preserved with 0.005% BAK, and travoprost 0.004% preserved with the proprietary preservative system sofZia in patients previously treated with latanoprost. (elsevierpure.com)
  • Methods: This randomized, multicenter, investigator-masked, parallel-group study enrolled patients with open-angle glaucoma or ocular hypertension who had been on latanoprost monotherapy for at least 4 weeks. (elsevierpure.com)
  • These results suggest that measuring the rate of structural change can provide important information for the clinical management of ocular hypertensive patients. (wustl.edu)
  • Ocular disorders among stroke patients. (who.int)
  • Thirty-nine patients (47.0%) were dearth of information on the pattern of ocular between ages of 51 and 60, while 1 (1.2%) was disorders in patients with stroke. (who.int)
  • PURPOSE: To report the characteristics of the steroid-induced ocular hypertensive response in pediatric patients with acute lymphoblastic leukemia (ALL) treated with prednisolone (PSL) during induction therapy and with dexamethasone (DEX) during reinduction therapy. (bvsalud.org)
  • 6 patients had symptoms of ocular hypertension. (bvsalud.org)
  • Knowledge of the clinical profile of patients who underwent penetrating keratoplasty enabled identification of the main ocular diagnoses that result in this type of transplant as a therapeutic indication. (bvsalud.org)
  • Conclusions: There were no significant differences among bimatoprost (preserved with 0.005% BAK), latanoprost (preserved with 0.02% BAK), and travoprost (preserved with sofZia) in objective clinical measures of ocular tolerability, including physician-graded hyperemia, corneal staining, and TBUT after 3 months of treatment. (elsevierpure.com)
  • Dynamic Gd-MRI was applied to examine the signal enhancement in AC and vitreous body upon microbead-induced ocular hypertension and unilateral topical applications of latanoprost, timolol maleate, and brimonidine tartrate to healthy eyes. (nyu.edu)
  • OBJECTIVE: To characterize clinical and clinicopathologic findings, response to treatment, and causes of systemic hypertension in cats with hypertensive retinopathy. (avmi.net)
  • PROCEDURE: Medical records from cats with systemic hypertension and hypertensive retinopathy were reviewed. (avmi.net)
  • Whether it's a result of obesity, illness, or hospital stress , systemic hypertension is usually an indicator of some other problem, and therefore important in the analysis of the patient. (furfarmandfork.com)
  • In this article, ocular hypertension refers to a state in which the eye(s) meet the above 5 criteria, in the absence of identifiable causes or cardinal signs of POAG. (medscape.com)
  • In the randomized, controlled, Ocular Hypertension Treatment Study (OHTS), the incidence of primary open-angle glaucoma (POAG) was analyzed in over 16,000 participants with ocular hypertension. (optometrytimes.com)
  • Purpose: To compare rates of topographic change in ocular hypertensive eyes that develop primary open-angle glaucoma (POAG) compared to eyes that do not, and to identify factors that influence the rate of change. (wustl.edu)
  • Immunoglobulin concentrations in human tears in ocular diseases. (bmj.com)
  • Gadolinium-enhanced MRI allows spatiotemporal and quantitative evaluation of altered AH dynamics and ocular tissue permeability for better understanding the physiological mechanisms of ocular hypertension and the efficacy of antiglaucoma drug treatments. (nyu.edu)
  • Longer-term studies are needed to further evaluate the ocular surface tolerability of these prostaglandin analogs. (elsevierpure.com)
  • The most commonly reported drug-related local adverse events were: ocular hyperemia, eyelashes growth, and eye irritation. (unimi.it)
  • Ocular hypertension is treated with prescription eye drops that can help aqueous humor drain from your eye or lower the amount of aqueous humor your eye produces. (rx2go.com)
  • Separation and disruption of the overlying ciliary epithelium decreases its production of aqueous humor with consequent ocular hypotension. (medscape.com)
  • These studies suggest that several of the ocular or optic nerve head ischemic or ocular vascular disorders previously thought to be manifestations of arterial hypertension may, in fact, be due to a combination of systemic arterial hypertension and hypotension, with arterial hypertension acting as a predisposing factor and arterial hypotension actually producing the disorders. (nih.gov)
  • The ocular inflammation can be induced by systemic injection of lipopolysaccharide (LPS), an endotoxin isolated from Gram-negative bacteria. (nature.com)
  • Ocular inflammation was induced in adult rats by injecting 1 mg/kg LPS into the left footpad. (nature.com)
  • A new study in the Journal of Clinical Medicine reveals ocular hypertension can have a protective effect against glaucoma, a leading cause of vision loss. (associatedeyewichita.com)
  • Assessment of cumulative incidence and severity of primary open-angle glaucoma among participants in the ocular Hypertension Treatment Study After 20 years of follow-up. (optometrytimes.com)
  • The current study aimed to investigate the association between PM 2.5 and ocular hypertension and to elucidate the mechanisms underlying this relationship. (biomedcentral.com)
  • Some of the limitations mentioned in the study were the fact that they lad a low sample of normotensive dogs with ocular lesions, and that diagnosis of hypertension is difficult due to situational stress interpretation in the face of blood pressure values and varied measurements within the "grey area" of test results. (furfarmandfork.com)
  • An interesting note is that all 5 dogs in the study that were currently taking Phenylpropanolamine either acutely or chronically were all hypertensive, supporting anecdotal evidence that it can promote hypertension. (furfarmandfork.com)
  • Methods: Four hundred forty-one participants (832 eyes) in the Confocal Scanning Laser Ophthalmoscopy Ancillary Study to the Ocular Hypertension Treatment Study were included. (wustl.edu)
  • Our objectives, therefore, were to investigate risk factors for POH and to test the hypothesis that perioperative topical ophthalmic dorzolamide hydrochloride 2%/timolol maleate 0.5% (DHTM) reduces the prevalence and/or severity of postoperative ocular hypertension (POH) in dogs undergoing cataract extraction by phacoemulsification (PE). (vt.edu)
  • Circumlimbal suture provides a simple and cost-effective way to induce mild chronic ocular hypertension in rat eyes. (arvojournals.org)
  • In the past decades, a number of animal models of glaucoma have been developed, 3 - 5 all of which aim to induce chronic ocular hypertension (OHT) and selective ganglion cell apoptosis. (arvojournals.org)
  • Hypertension was diagnosed concurrently with chronic renal failure (n = 22), hyperthyroidism (5), diabetes mellitus (2), and hyperaldosteronism (1). (avmi.net)
  • CONCLUSIONS AND CLINICAL RELEVANCE: Retinal lesions, caused predominantly by choroidal injury, are common in cats with hypertension. (avmi.net)
  • Postoperative ocular hypertension (POH) describes the elevation of pressures within the eye during the acute postoperative period and can result in vision loss and poor surgical outcome. (vt.edu)
  • Chart review was performed seeking preoperative and postoperative data on risk factors for ocular hypertension after PKP. (glaucoma.org.il)
  • Ocular hypertension appeared after a mean postoperative period of 70.3+/-15.8 days, and continued for an average period of 15.6+/-2.0 days. (glaucoma.org.il)
  • Notice that most have elevated pressure but no sign of damage (ie, ocular hypertensives), but there are those with normal pressures who still have damage from glaucoma (ie, normal tension glaucoma). (medscape.com)
  • The condition is diagnosed using ocular tonometry and glaucoma evaluation. (wikipedia.org)
  • The following information was collected on standardized data collection sheets: demographics, medical history, ocular family history, and complete ophthalmic examination including visual fields. (hindawi.com)
  • Ocular examination. (ijo.in)
  • Therefore, regular examination of your eyes is imperative if you have ocular hypertension. (rx2go.com)
  • An eye examination is a primary method to diagnose ocular hypertension. (rx2go.com)
  • The LiGHT trial compared the effectiveness of eye drops and selective laser trabeculoplasty for ocular hypertension and open angle glaucoma. (wikipedia.org)
  • Despite early definitions, ocular hypertension has historically meant different things to different ophthalmologists. (medscape.com)
  • Development of cataracts is a relatively frequent ocular disease of the dog and cataract extraction via phacoemulsification (PE) is commonly performed by veterinary ophthalmologists. (vt.edu)
  • Cats with hypertension-induced ocular disease should be evaluated for renal failure, hyperthyroidism, diabetes mellitus, and cardiac abnormalities. (avmi.net)
  • Many of the ocular abnormalities are as a result of long-standing uncontrolled hypertension which caused the stroke. (who.int)
  • History of hypertension was negatively, and older age and family history of glaucoma were positively, associated with glaucoma. (who.int)
  • This study's findings suggest visual field loss may be an early sign of ocular hypertension. (optometrytimes.com)
  • All in all, a good article, and a good look at the relationship between ocular findings and hypertension. (furfarmandfork.com)
  • Because ocular hypertension creates no outward signs or symptoms, it is wise to regularly visit your eye care professional to have the pressure in your eye measured and ensure that the condition is properly managed before it leads to a more serious problem. (spectaculareyewear.net)
  • To describe the distribution of ocular variables, risk factors, and disease severity in newly diagnosed ocular hypertension (OH) or open-angle glaucoma (OAG). (hindawi.com)
  • We tested linkage of OAG and ocular hypertension (OHT), a major risk factor for OAG, to GLC1A in eight French families with multiple cases of juvenile and middle age onset OAG. (nih.gov)
  • Risk of hypertension and bradycardia. (medscape.com)
  • Primary hypertension in cats may be more common than currently recognized. (avmi.net)
  • There are well-known associations between systemic arterial hypertension and a variety of ocular disorders that were previously considered to be primarily manifestations of arterial hypertension. (nih.gov)
  • It is estimated that approximately 2-3% of people aged 52-89 years old have ocular hypertension of 25 mmHg and higher, and 3.5% of people 49 years and older have ocular hypertension of 21 mmHg and higher. (wikipedia.org)
  • Ocular hypertension is a potentially serious complication after penetrating keratoplasty (PKP). (glaucoma.org.il)
  • Evaluation of the myocilin (MYOC) glaucoma gene in monkey and humansteroid-induced ocular hypertension. (jamanetwork.com)
  • In addition to improving the outflow function of the trabecular meshwork, Rho kinase inhibitors have been shown to increase ocular blood flow and to enhance retinal ganglion cell survival after ischemic injury. (entokey.com)